<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article article-type="research-article" dtd-version="1.2" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">74211</article-id><article-id pub-id-type="doi">10.7554/eLife.74211</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Medicine</subject></subj-group></article-categories><title-group><article-title>Pericyte-mediated constriction of renal capillaries evokes no-reflow and kidney injury following ischaemia</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-99706"><name><surname>Freitas</surname><given-names>Felipe</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4627-3509</contrib-id><email>f.freitas@ucl.ac.uk</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-2458"><name><surname>Attwell</surname><given-names>David</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3618-0843</contrib-id><email>d.attwell@ucl.ac.uk</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02jx3x895</institution-id><institution>Department of Neuroscience, Physiology and Pharmacology, University College London</institution></institution-wrap><addr-line><named-content content-type="city">London</named-content></addr-line><country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Nelson</surname><given-names>Mark T</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0155zta11</institution-id><institution>University of Vermont</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Pollak</surname><given-names>Martin R</given-names></name><role>Senior Editor</role><aff><institution>Harvard Medical School</institution><country>United States</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>14</day><month>03</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>11</volume><elocation-id>e74211</elocation-id><history><date date-type="received" iso-8601-date="2021-09-25"><day>25</day><month>09</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2022-03-09"><day>09</day><month>03</month><year>2022</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at .</event-desc><date date-type="preprint" iso-8601-date="2021-09-24"><day>24</day><month>09</month><year>2021</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2021.09.24.461675"/></event></pub-history><permissions><copyright-statement>© 2022, Freitas and Attwell</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Freitas and Attwell</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-74211-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-74211-figures-v2.pdf"/><abstract><p>Acute kidney injury is common, with ~13 million cases and 1.7 million deaths/year worldwide. A major cause is renal ischaemia, typically following cardiac surgery, renal transplant or severe haemorrhage. We examined the cause of the sustained reduction in renal blood flow (‘no-reflow’), which exacerbates kidney injury even after an initial cause of compromised blood supply is removed. Adult male Sprague-Dawley rats, or NG2-dsRed male mice were used in this study. After 60 min kidney ischaemia and 30–60 min reperfusion, renal blood flow remained reduced, especially in the medulla, and kidney tubule damage was detected as Kim-1 expression. Constriction of the medullary descending vasa recta and cortical peritubular capillaries occurred near pericyte somata, and led to capillary blockages, yet glomerular arterioles and perfusion were unaffected, implying that the long-lasting decrease of renal blood flow contributing to kidney damage was generated by pericytes. Blocking Rho kinase to decrease pericyte contractility from the start of reperfusion increased the post-ischaemic diameter of the descending vasa recta capillaries at pericytes, reduced the percentage of capillaries that remained blocked, increased medullary blood flow and reduced kidney injury. Thus, post-ischaemic renal no-reflow, contributing to acute kidney injury, reflects pericytes constricting the descending vasa recta and peritubular capillaries. Pericytes are therefore an important therapeutic target for treating acute kidney injury.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>kidney</kwd><kwd>pericyte</kwd><kwd>capillary</kwd><kwd>ischemia</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd><kwd>Rat</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000833</institution-id><institution>Rosetrees Trust and Stoneygate Trust</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Freitas</surname><given-names>Felipe</given-names></name><name><surname>Attwell</surname><given-names>David</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100004440</institution-id><institution>Wellcome Trust</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Attwell</surname><given-names>David</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000781</institution-id><institution>European Research Council</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Attwell</surname><given-names>David</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Renal capillary pericytes are a novel therapeutic target for reducing sustained reduction in renal blood flow ('no-reflow') after kidney ischaemia.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The global burden of acute kidney injury is approximately 13 million cases a year (<xref ref-type="bibr" rid="bib78">Ponce and Balbi, 2016</xref>). It is associated with a high mortality (1.7 million deaths per year, worldwide) (<xref ref-type="bibr" rid="bib26">Gameiro et al., 2018</xref>; <xref ref-type="bibr" rid="bib34">Hoste et al., 2018</xref>; <xref ref-type="bibr" rid="bib62">Mehta et al., 2016</xref>), and COVID-19 has added to its incidence (<xref ref-type="bibr" rid="bib86">Ronco et al., 2020</xref>). Renal ischaemia followed by reperfusion, which can occur after cardiac surgery, renal transplant, or severe haemorrhage, is the most common cause of acute kidney injury (<xref ref-type="bibr" rid="bib50">Lameire et al., 2006</xref>; <xref ref-type="bibr" rid="bib49">Lameire and Vanholder, 2001</xref>). Sustained renal blood flow reductions occur after ischaemia and reperfusion, both in experimental studies and in patients after kidney transplantation (<xref ref-type="bibr" rid="bib17">Cristol et al., 1996</xref>; <xref ref-type="bibr" rid="bib67">Nijveldt et al., 2001</xref>; <xref ref-type="bibr" rid="bib82">Ramaswamy et al., 2002</xref>). Following short periods of ischaemia, blood flow to the renal cortex largely recovers following reperfusion, but medullary blood flow remains reduced for a prolonged period, especially in the hypoxia-sensitive outer medulla (the organisation of kidney areas and vasculature is shown in our summary Figure 8 below). Medullary no-reflow is a critical event for amplifying renal tissue injury following reperfusion (<xref ref-type="bibr" rid="bib14">Conesa et al., 2001</xref>; <xref ref-type="bibr" rid="bib70">Olof et al., 1991</xref>; <xref ref-type="bibr" rid="bib83">Regner et al., 2009</xref>).</p><p>Renal no-reflow has been attributed to various causes, including impaired erythrocyte movement and leukocyte accumulation in renal capillaries, as well as increased intratubular pressure (<xref ref-type="bibr" rid="bib10">Bonventre and Weinberg, 2003</xref>; <xref ref-type="bibr" rid="bib98">Sutton et al., 2002</xref>; <xref ref-type="bibr" rid="bib107">Wei et al., 2017</xref>; <xref ref-type="bibr" rid="bib111">Yamamoto et al., 2002</xref>). However, after years of investigation, no effective treatment is available, even though no-reflow predicts a worse prognosis after kidney ischaemia. We therefore investigated an alternative possible cause of no-reflow, that is ischaemia-evoked contraction of pericytes that regulate capillary diameter, which might reduce renal blood flow and physically trap red blood cells. Indeed, in the brain and heart contractile pericytes on capillaries play a key role in reducing blood flow after ischaemia (<xref ref-type="bibr" rid="bib29">Hall et al., 2014</xref>; <xref ref-type="bibr" rid="bib71">O’Farrell et al., 2017</xref>; <xref ref-type="bibr" rid="bib113">Yemisci et al., 2009</xref>) because capillaries remain constricted by pericytes even when blood flow is restored to upstream arterioles. In the retina it has been shown that this capillary constriction is mediated by α-smooth muscle actin (α-SMA) based actomyosin-mediated contraction of capillary pericytes (<xref ref-type="bibr" rid="bib3">Alarcon-Martinez et al., 2019</xref>). In the kidney, pericytes are associated with the cortical and medullary peritubular capillaries and the descending vasa recta. As in the retina, pericyte populations in the kidney, particularly those in the descending vasa recta, are associated with α-SMA expression and contractility (<xref ref-type="bibr" rid="bib74">Park et al., 1997</xref>; <xref ref-type="bibr" rid="bib90">Shaw et al., 2018</xref>). They play a key role in regulating renal medullary blood flow (<xref ref-type="bibr" rid="bib15">Crawford et al., 2012</xref>; <xref ref-type="bibr" rid="bib72">Pallone and Silldorff, 2001</xref>) which is a crucial variable for meeting the contradictory demands of preserving cortico-medullary osmotic gradients to allow water retention in the body, while maintaining adequate oxygen and nutrient delivery. This raises the question of whether pericytes also play a role in generating renal no-reflow after ischaemia.</p><p>An important regulator of pericyte contractility is the Rho kinase pathway (<xref ref-type="bibr" rid="bib20">Durham et al., 2014</xref>; <xref ref-type="bibr" rid="bib45">Kutcher et al., 2007</xref>), which inhibits myosin phosphatase, thus increasing phosphorylation of myosin light chain (MLC) and increasing contraction (<xref ref-type="bibr" rid="bib41">Kimura et al., 1996</xref>; <xref ref-type="bibr" rid="bib58">Maeda et al., 2003</xref>). Overactivity of Rho kinase may play a key role in hypertension and diabetes, as well as in kidney ischaemia (<xref ref-type="bibr" rid="bib36">Jahani et al., 2018</xref>; <xref ref-type="bibr" rid="bib44">Kushiyama et al., 2013</xref>; <xref ref-type="bibr" rid="bib76">Peng et al., 2008</xref>; <xref ref-type="bibr" rid="bib95">Soga et al., 2011</xref>; <xref ref-type="bibr" rid="bib103">Versteilen et al., 2006</xref>). Rho kinase may also regulate pericyte contractility by modulating actin polymerisation (<xref ref-type="bibr" rid="bib43">Kureli et al., 2020</xref>; <xref ref-type="bibr" rid="bib46">Kutcher and Herman, 2009</xref>; <xref ref-type="bibr" rid="bib59">Maekawa et al., 1999</xref>; <xref ref-type="bibr" rid="bib116">Zhang et al., 2018a</xref>). In ischaemia, an important pathway by which Rho kinase inhibits myosin phosphatase is via inactivation of endothelial nitric oxide synthase (eNOS) (<xref ref-type="bibr" rid="bib103">Versteilen et al., 2006</xref>), thus reducing production of nitric oxide (NO). NO acts on guanylate cyclase to raise the concentration of cyclic GMP, which increases MLC phosphatase activity and thus decreases contraction, so inhibiting eNOS will increase MLC phosphorylation and contraction. Thus, both the direct effect of Rho kinase (<xref ref-type="bibr" rid="bib41">Kimura et al., 1996</xref>; <xref ref-type="bibr" rid="bib58">Maeda et al., 2003</xref>) and its actions on eNOS (<xref ref-type="bibr" rid="bib103">Versteilen et al., 2006</xref>) converge to promote MLC phosphorylation and contraction. Rho kinase is an important effector of vasoconstrictors such as endothelin-1 (<xref ref-type="bibr" rid="bib79">Prakash et al., 2008</xref>; <xref ref-type="bibr" rid="bib109">Wilhelm et al., 1999</xref>; <xref ref-type="bibr" rid="bib110">Yamamoto et al., 2000</xref>) and angiotensin II (<xref ref-type="bibr" rid="bib87">Rupérez et al., 2005</xref>), but its effects on pericytes are under-studied, although it may control their contractility (<xref ref-type="bibr" rid="bib20">Durham et al., 2014</xref>; <xref ref-type="bibr" rid="bib30">Hartmann et al., 2021</xref>; <xref ref-type="bibr" rid="bib33">Homma et al., 2014</xref>; <xref ref-type="bibr" rid="bib45">Kutcher et al., 2007</xref>; <xref ref-type="bibr" rid="bib75">Pearson et al., 2013</xref>).</p><p>Few studies have investigated how ischaemia affects renal pericytes (<xref ref-type="bibr" rid="bib48">Kwon et al., 2008</xref>; <xref ref-type="bibr" rid="bib60">McCurley et al., 2017</xref>; <xref ref-type="bibr" rid="bib117">Zhang et al., 2018b</xref>), and whether pericytes contribute to renal no-reflow. However, peritubular pericytes are damaged in cortical tissue of cadaveric renal allografts following ischaemia-reperfusion (<xref ref-type="bibr" rid="bib48">Kwon et al., 2008</xref>), suggesting that renal blood flow control may be disrupted after ischaemia by pericyte dysfunction. Here, we show that pericyte-mediated capillary constriction, especially of the descending vasa recta, makes a crucial contribution to no-reflow following renal ischaemia and reperfusion. We further show that targeting pericyte-mediated constriction pharmacologically can reduce ischaemia-evoked acute kidney injury.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>No-reflow after renal ischaemia and reperfusion</title><p>Adult male Sprague-Dawley rats (P40-50), or NG2-dsRed male mice (P100-120) were used in this study. We used a combination of laser Doppler perfusion measurements, low magnification imaging of blood volume, and high magnification imaging that resolved individual capillaries, to assess the magnitude and cause of changes of renal perfusion after ischaemia. Ischaemia for 1 hr decreased perfusion of the renal medulla and cortex by ~90% (both <italic>P</italic> &lt; 0.0001 vs. control; assessed with laser Doppler: <xref ref-type="fig" rid="fig1">Figure 1a and b</xref>). After 30 min reperfusion, blood flow recovered to 49% of control (significantly reduced, <italic>P</italic> = 0.005, <xref ref-type="fig" rid="fig1">Figure 1a</xref>) in the medulla, but to 75% in the cortex (<italic>P</italic> = 0.047, <xref ref-type="fig" rid="fig1">Figure 1b</xref>; <xref ref-type="bibr" rid="bib83">Regner et al., 2009</xref>). Perfusion was stable in the contralateral kidney throughout (<xref ref-type="fig" rid="fig1">Figure 1a and b</xref>). After 60 min reperfusion, medullary perfusion remained compromised at 40% of the control level (<italic>P</italic> = 0.017, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1a</xref>), but cortical perfusion had fully recovered (to ~20% above the control value, not significant, <italic>P</italic> = 0.092, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1b</xref>). Despite this flow recovery, we show below that peritubular capillaries in the cortex can become blocked after ischaemia.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Ischaemia and reperfusion lead to cortical and medullary no-reflow.</title><p>(<bold>a, b</bold>) Ischaemia and reperfusion (I/R) evoked changes of blood flow (measured by laser Doppler) in the rat renal (<bold>a</bold>) medulla (n = 4 animals) and (<bold>b</bold>) cortex (n = 10 animals). CONT indicates blood flow on the contralateral (non-ischaemic) side. Traces labelled +HF show the effect on recovery of perfusion of administering the Rho kinase inhibitor hydroxyfasudil (HF) immediately on reperfusion (I/<italic>R</italic> + HF) (n = 4 animals). (<bold>c–e</bold>) <bold>Top:</bold> low power views of kidney slices after perfusion in vivo with FITC-albumin gelatin, from (<bold>c</bold>) control (contralateral) kidney, (<bold>d</bold>) a kidney after ischaemia and 30 min reperfusion, and (<bold>e</bold>) a kidney 30 min after treatment with HF on reperfusion <bold>Bottom:</bold> regions of interest (ROIs) are shown in red and blue for the cortex and medulla. (<bold>f</bold>) Medullary perfusion (assessed in slices of fixed kidney as the total intensity of FITC-albumin summed over the ROIs) was reduced after 30 min of post-ischaemic reperfusion (51 stacks, 6 animals) by ~50% compared with control kidneys (52 stacks, 7 animals). Treatment with HF increased medullary perfusion 2.3-fold at this time compared with non-treated ischaemic kidneys (20 stacks, 4 animals). (<bold>g</bold>) Cortex perfusion (assessed as in c-e) after 30 min of reperfusion after ischaemia was reduced by ~23.5% compared with control kidneys. Treatment with HF (I/<italic>R</italic> + HF) increased cortex perfusion by 25% at this time compared with non-treated ischaemic kidneys (I/R). Data are mean ± s.e.m. <italic>P</italic> values are corrected for multiple comparisons. Statistical tests used the number of animals as the N value (not the stack number).</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Ischaemia and reperfusion lead to cortical and medullary no-reflow.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-74211-fig1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-74211-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Ischaemia (I/R) evoked changes of blood flow measured by laser Doppler in the rat renal medulla and cortex.</title><p>(<bold>a, b</bold>) Ischaemia (I/R) evoked changes of blood flow (measured by laser Doppler) in the rat renal (<bold>a</bold>) medulla (n = 3 animals) and (<bold>b</bold>) cortex (n = 3 animals). CONT indicates blood flow on the contralateral (non-ischaemic) side. At 60 min following reperfusion, medullary perfusion remained compromised at 40% of its control value (<italic>P</italic> = 0.017), but cortical perfusion was fully recovered (to ~20% above the control value, although this did not reach significance, <italic>P</italic> = 0.092). (<bold>c</bold>) Hydroxyfasudil (3 mg/kg; i.v.) (n = 4 animals) treatment immediately after reperfusion (I/<italic>R</italic> + HF) induced a faster recovery to the pre-ischaemic value of of medullary blood flow than did BQ123 (0.5 mg/kg, i.v., given on reperfusion: I/<italic>R</italic> + BQ123) (n = 3 animals), a selective endothelin-A receptor antagonist. After 30 min reperfusion both agents resulted in blood flow that was not significantly different from control (<italic>P</italic> = 0.8 and <italic>P</italic> = 0.38, respectively) but was significantly different from ischaemia (<italic>P</italic> = 0.01 for both drugs). Valsartan (1 mg/kg i.v., given on reperfusion: I/<italic>R</italic> + VAL) (n = 2 animals), an angiotensin II type 1 (AT1) receptor antagonist, increased medullary perfusion by 52% after 30 min reperfusion compared with non-treated ischaemic kidneys, although this did not reach significance (<italic>P</italic> = 0.11 vs. I/R) and valsartan had not reversed medullary blood flow to the baseline level after 30 mins (<italic>P</italic> = 0.19 vs. CONT). (<bold>d</bold>) Recovery of cortical blood flow to its control level on reperfusion was faster in the presence of hydroxyfasudil (I/<italic>R</italic> + HF) (n = 4 animals). BQ123 (n = 4 animals) (<italic>P</italic> = 0.05 vs. I/R) and valsartan (n = 3 animals) (<italic>P</italic> = 0.04 vs. I/R) also promoted recovery of cortical blood flow at 30 min reperfusion compared with non-treated ischaemic kidneys (I/R). Statistical tests used the number of animals as the N value.</p><p><supplementary-material id="fig1s1sdata1"><label>Figure 1—figure supplement 1—source data 1.</label><caption><title>Ischaemia (I/R) evoked changes of blood flow measured by laser Doppler in the rat renal medulla and cortex.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-74211-fig1-figsupp1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-74211-fig1-figsupp1-v2.tif"/></fig></fig-group><p>After ischaemia and reperfusion in vivo, assessing the volume of perfused vessels in fixed kidney slices, as the summed FITC-albumin intensity over ROIs, also demonstrated that renal ischaemia and reperfusion led to no-reflow in the medulla compared with the non-ischaemic kidney’s medulla (the perfusing blood volume was reduced by ~50%, <italic>P</italic> = 0.002; <xref ref-type="fig" rid="fig1">Figure 1c, d and f</xref>). Microscopic analysis resolving individual capillaries showed that this blood volume reduction was associated with a large reduction in capillary perfusion (<xref ref-type="fig" rid="fig2">Figure 2</xref>). The total perfused capillary length in 100 µm deep confocal z-stacks (frame size 640.17 × 640.17 µm) was reduced by 35% (contralateral control 14689 ± 3477 µm vs. ischaemia 9527 ±1183 µm, <italic>P</italic> = 0.038), the number of perfused capillary segments was reduced by 54% (control 530 ± 82 vs. ischaemia 244 ± 30, <italic>P</italic> = 0.03), and the overall perfused microvascular volume fraction was reduced by 51% (control 0.116 ± 0.006 vs. ischaemia 0.057 ± 0.006, <italic>P</italic> = 0.003; <xref ref-type="fig" rid="fig2">Figure 2e–g</xref>).</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Ischaemia and reperfusion reduce medullary microvascular perfusion.</title><p>(<bold>a</bold>) Representative images of slices after perfusion with FITC-albumin gelatin, showing the rat kidney microcirculation in 100 µm deep confocal z-stacks. Images depict renal cortical arterioles, the glomeruli and peritubular capillaries, as well as the vasa recta capillaries (VR) that supply blood to the renal medulla. (<bold>b–d</bold>) Representative images of the medullary microcirculation: (<bold>b</bold>) in control conditions (CONT), (<bold>c</bold>) after ischaemia and 30 min reperfusion (I/R), and (<bold>d</bold>) after ischaemia and reperfusion for 30 min with hydroxyfasudil (HF) applied during reperfusion (I/<italic>R</italic> + HF). Images show NG2-labelling of pericytes (red), FITC-albumin labeling (green) of vessels that are perfused, a merge of the NG2 and FITC-albumin images, and the analysed skeleton (yellow) of the perfused microvessels. (<bold>e–g</bold>) After ischaemia and reperfusion (12 stacks, 4 animals), the total perfused capillary length (<bold>e</bold>), the number of perfused capillary segments (<bold>f</bold>) and the overall volume fraction of vessels perfused (<bold>g</bold>) in 100 µm deep confocal z-stacks were reduced compared with control kidneys (14 stacks, 6–7 animals), and treatment with hydroxyfasudil immediately after reperfusion (10 stacks, 4 animals) increased all of these parameters.Data are mean ± s.e.m. <italic>P</italic> values are corrected for multiple comparisons. Statistical tests used the number of animals as the N value (not the stack number).</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Ischaemia and reperfusion reduce medullary microvascular perfusion.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-74211-fig2-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-74211-fig2-v2.tif"/></fig><p>In the cortex, perfusion was reduced less than in the medulla after ischaemia and reperfusion, that is by 23.5% compared with non-ischaemic kidneys (<italic>P</italic> = 0.0075, <xref ref-type="fig" rid="fig1">Figure 1c, d and g</xref>). Furthermore, although a small percentage of afferent and efferent arterioles, and glomeruli, were not perfused in control conditions, this percentage did not increase significantly after ischaemia (<xref ref-type="fig" rid="fig3">Figure 3a, b and g</xref>), and the arterioles’ diameter was not reduced compared with those in non-ischaemic kidneys (<xref ref-type="fig" rid="fig3">Figure 3a, b, h and i</xref>). Similarly, it has been reported that upstream arteries are not constricted after ischaemia (<xref ref-type="bibr" rid="bib111">Yamamoto et al., 2002</xref>). In contrast, the total perfused peritubular capillary length in the 100 µm deep z-stacks (control 16441 ± 1577 µm vs. ischaemia 5411 ±2735 µm, reduced by 67%, <italic>P</italic> = 0.03), the number of perfused capillary segments (control 550 ± 32 µm vs. ischaemia 349 ±54, reduced by 36.5%, <italic>P</italic> = 0.01) and the overall perfused peritubular capillary volume fraction (control 0.12 ± 0.01 vs. ischaemia 0.06 ± 0.02, reduced by 50%, <italic>P</italic> = 0.01) were greatly reduced in the cortex when compared with non-ischaemic kidneys (<xref ref-type="fig" rid="fig3">Figure 3d–f</xref>). Thus, the effect of ischaemia and reperfusion is predominantly on the microvasculature, that is the peritubular cortical capillaries and the vasa recta, rather than on arteriolar segments of the kidney circulation. The Rho kinase inhibition data shown in <xref ref-type="fig" rid="fig3">Figure 3</xref> are discussed below.</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Ischaemia and reperfusion of renal cortex evoke no-reflow in capillaries but not arterioles.</title><p>(<bold>a–c</bold>) Representative images of rat renal cortex slices containing arterioles, glomeruli and peritubular capillaries, after perfusion with FITC-albumin gelatin: (<bold>a</bold>) for control kidneys (CONT), (<bold>b</bold>) after ischaemia and reperfusion (I/R), and (<bold>c</bold>) after ischaemia with hydroxyfasudil (I/<italic>R</italic> + HF). NG2-labelling (red) is seen of arterioles (blue arrowheads) and pericytes (yellow arrowheads), while FITC-albumin labelling (green) shows vessels that are perfused. (<bold>d-f</bold>) After ischaemia and reperfusion (I/R) (12 stacks, 6 animals), the total perfused capillary length (<bold>d</bold>), the number of perfused segments (<bold>e</bold>), and the overall perfused microvascular volume fraction (<bold>f</bold>) were reduced compared with control kidneys (CONT) (14 stacks, 7 animals), and treatment with hydroxyfasudil immediately after reperfusion (I/<italic>R</italic> + HF) (10 stacks, 4 animals) increased cortical microvascular perfusion compared with non-treated ischaemic kidneys. (<bold>g</bold>) Percentage of afferent and efferent arterioles (blue arrowheads in a-c), and of glomeruli (white arrowheads), perfused after ischaemia, compared with control conditions. (<bold>h–i</bold>) Diameters of perfused (<bold>h</bold>) afferent and (<bold>i</bold>) efferent arterioles in the renal cortex for the three experimental conditions (15 arterioles, 4 animals for each group). Data are mean ± s.e.m. <italic>P</italic> values are corrected for multiple comparisons.Statistical tests used the number of animals as the N value (not the stack number).</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Ischaemia and reperfusion of renal cortex evoke no-reflow in capillaries but not arterioles.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-74211-fig3-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-74211-fig3-v2.tif"/></fig></sec><sec id="s2-2"><title>Pericytes constrict descending vasa recta after ischaemia and reperfusion</title><p>Higher magnification images demonstrated that, in control kidneys, only 9.7% of the descending vasa recta (DVR) capillaries were blocked (<xref ref-type="fig" rid="fig2">Figures 2b</xref> and <xref ref-type="fig" rid="fig4">4d</xref>), that is were not perfused by FITC-albumin (<xref ref-type="fig" rid="fig2">Figures 2c</xref> and <xref ref-type="fig" rid="fig4">4a–d</xref>). However, after ischaemia and 30 mins reperfusion, 78% of the DVR capillaries were blocked (<xref ref-type="fig" rid="fig2">Figures 2c</xref> and <xref ref-type="fig" rid="fig4">4a–d</xref>). Some capillaries were fully perfused and some completely unperfused throughout the area assessed, whereas some exhibited an abrupt cessation of blood flow with a decrease of FITC-albumin intensity over a few microns (<xref ref-type="fig" rid="fig2">Figures 2c</xref> and <xref ref-type="fig" rid="fig4">4a–c</xref>). At block sites, the diameter of the FITC-albumin lumenal labelling at the final position blood reached was significantly lower in ischaemic DVR capillaries compared with that at the much smaller number of block sites in non-ischaemic controls (control 6.5 ± 0.3 µm vs. ischaemia 3.5 ± 0.4 µm; <italic>P</italic> = 0.039, <xref ref-type="fig" rid="fig4">Figure 4e</xref>). Thus, an ischaemia-induced constriction of the DVR promotes blockage, which persists even after reperfusion.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Descending vasa recta are constricted by pericytes after ischaemia.</title><p>(<bold>a</bold>) Descending vasa recta (DVR) in slices of rat renal medulla after perfusion with FITC-albumin gelatin (re-coloured red), and labelled for pericytes with antibody to the proteoglycan NG2 (green); FITC-albumin labelling shows perfused and blocked vessels. White arrow indicates flow direction; white lines indicate blocked vessels. (<bold>b–c</bold>) Representative images showing DVR capillaries blocked near pericyte somata. NG2-labelling of pericytes shows pericyte processes presumed to be constricting vessels at block site. (<bold>d</bold>) Percentage of DVR capillaries blocked in the renal medulla in control conditions (CONT) (127 capillaries, 12 stacks, 9 animals), after ischaemia and reperfusion (I/R) (77 capillaries, 10 stacks, 6 animals), and after ischaemia with hydroxyfasudil present in the reperfusion period (IR + HF) (60 capillaries, 8 stacks, 4 animals). Statistical tests used number of animals as the N value. (<bold>e</bold>) Diameter at block sites. (<bold>f</bold>) Probability distribution per 2.5 μm bin of distance from blockage to nearest pericyte soma after ischaemia and reperfusion (for 27 block sites), and of the distance between adjacent pericytes on DVR capillaries (for 118 pericyte pairs). (<bold>g</bold>) DVR diameter versus distance from pericyte somata (10 µm is approximately half the separation between pericytes) in the same three conditions as d (number of pericytes was 31, 20, and 17 respectively). <italic>P</italic> values by each point are from t-tests. Slope of the best-fit ISCH regression line is significantly greater than zero (<italic>P</italic> = 0.039) while that of the CONT line is not (<italic>P</italic> = 0.084). Data are mean ± s.e.m.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Descending vasa recta are constricted by pericytes after ischaemia.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-74211-fig4-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-74211-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>The effect of renal ischaemia and reperfusion on red blood cell trapping and endothelial glycocalyx integrity in the descending vasa recta.</title><p>(<bold>a</bold>) Red blood cells (RBCs, indicated by yellow arrowheads, labelled for glycophorin A) were associated with a small percentage of blockage sites (indicated by blue arrowheads) in ischaemic rat kidneys (5.8% of 85 blockages from 137 vessels analysed from two animals), and even where red blood cells were near the capillary blockages it did not always lead to a block of blood flow (as shown by FITC-albumin, re-coloured white, passing the red blood cells [purple arrow]). Note that the vasculature was perfused with PBS to remove loose RBCs before perfusing PFA and FITC-albumin, so the only RBCs remaining should be those bound to the vessel walls. (<bold>b</bold>) Percentage of DVR that were blocked, and percentage of blocked DVR that had an associated RBC. (<bold>c</bold>) Endothelial glycocalyx (eGCX) was labelled in vivo using wheat germ agglutinin-Alexa Fluor 647 (WGA, re-coloured green). White boxes show ROIs for measuring eGCX mean fluorescence intensities at different distances from the pericyte soma. (<bold>d</bold>) Plots of WGA signal across capillary at different distances from arrowed pericyte in (<bold>c</bold>). (<bold>e</bold>) eGCX is fairly evenly distributed along the vessel wall in normal kidneys (CONT), and also after ischaemia and reperfusion (I/R). Blockages (indicated by blue arrowheads) are highly associated with pericyte location (indicated by white arrowheads) in ischaemic kidneys (I/R). (<bold>f</bold>) Mean level of eGCX averaged across vessel at different distances from the pericyte soma in control kidney and after ischaemia with 30 min reperfusion. For the control condition, black <italic>P</italic> values compare the value at each position with that at the soma. Red <italic>P</italic> values compare the ischaemic and control groups for each position. (<bold>g</bold>) eGCX mean fluorescence averaged over all positions measured. (<bold>h</bold>) eGCX intensity and diameter have no correlation in control or ischaemic conditions. Data are mean ± s.e.m, 30 pericytes from two animals for each experimental condition. Statistical tests used the number of pericytes as the N value.</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>The effect of renal ischaemia and reperfusion on red blood cell trapping and endothelial glycocalyx integrity in the descending vasa recta.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-74211-fig4-figsupp1-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4s1sdata2"><label>Figure 4—figure supplement 1—source data 2.</label><caption><title>The effect of renal ischaemia and reperfusion on red blood cell trapping and endothelial glycocalyx integrity in the descending vasa recta.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-74211-fig4-figsupp1-data2-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-74211-fig4-figsupp1-v2.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>Morphology of renal pericytes.</title><p>(<bold>a</bold>) Cortical pericyte showing longitudinal processes and a limited number of circumferential processes. (<bold>b</bold>) Medullary pericytes showing a large number of circumferential processes.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-74211-fig4-figsupp2-v2.tif"/></fig></fig-group><p>Erythrocyte protein glycophorin A was labelled to assess if red blood cells were trapped at capillary regions of reduced diameter. Red blood cells were associated with only a small percentage of blockage sites in ischaemic kidneys (5.8% of 85 blockages in 137 vessels from two animals), and even where red blood cells were near the capillary blockages they did not always block blood flow because FITC-albumin could pass the red blood cells (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1a, b</xref>).</p><p>In the brain (<xref ref-type="bibr" rid="bib29">Hall et al., 2014</xref>; <xref ref-type="bibr" rid="bib113">Yemisci et al., 2009</xref>) and heart (<xref ref-type="bibr" rid="bib71">O’Farrell et al., 2017</xref>), post-ischaemic capillary constriction reflects pericyte contraction, which occurs near pericyte somata where circumferential processes originate (<xref ref-type="bibr" rid="bib69">Nortley et al., 2019</xref>). From NG2 labelling, we observed that many DVR blockages were close to pericyte somata, or near to pericyte circumferential processes connected to the soma (<xref ref-type="fig" rid="fig4">Figure 4b–c</xref>), suggesting that contraction of these juxta-somatic processes evoked capillary block. We measured the distance of 27 blockages to the nearest pericyte soma. The probability distribution of this distance is compared with that of the inter-pericyte distance in <xref ref-type="fig" rid="fig4">Figure 4f</xref> (if blocks did not depend on pericytes, the probability distribution of the blockage-pericyte distance would be constant until half the distance between pericytes). The mean blockage-pericyte distance was 4.87 ± 0.33 µm after ischaemia and reperfusion, which is less than a quarter of the distance between DVR pericytes (22.85 ± 0.93 µm, from 118 pericyte pairs). Thus, these data are consistent with pericyte constriction generating the DVR blockages.</p><p>In control conditions, the few blockages occurring were mainly in regions where the inter-pericyte distance was larger. The mean distance from a blockage to the nearest pericyte soma was also larger (14.98 ± 1.36 µm, <italic>P</italic> &lt; 0.0001 compared to post-ischaemia), suggesting a different block mechanism in control conditions.</p><p>To assess pericyte-mediated DVR constriction further, we measured the FITC-albumin labelled lumen diameter at 5 µm intervals upstream of pericyte somata (upstream so there was FITC-albumin in the vessel: <xref ref-type="fig" rid="fig4">Figure 4g</xref>). After ischaemia and reperfusion, the diameter was significantly reduced (by 41%, <italic>P</italic> = 0.0001) near the pericyte somata compared with non-ischaemic kidneys, but less reduced further from the somata. The diameter significantly increased with distance from the somata after ischaemia and reperfusion (<italic>P</italic> = 0.039 comparing the slope of the best-fit ischaemia regression line with zero) but not in control conditions (<italic>P</italic> = 0.084), implying constriction preferentially near the pericyte somata (<xref ref-type="fig" rid="fig4">Figure 4g</xref>) and identifying pericytes as the origin of the diameter reduction. Such constrictions will reduce blood flow directly by increasing the vascular resistance, and may also lead to blood cells becoming trapped at the regions of narrowed diameter, thus occluding the vessel and further reducing blood flow.</p><p>We assessed whether the endothelial glycocalyx (eGCX) contributed to DVR blockages. Labelling showed that eGCX is fairly uniformly present along capillaries, and this was not altered after ischaemia (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1f-g</xref>). There was no correlation between eGCX intensity and capillary diameter in control or ischaemic conditions (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1h</xref>). Thus, eGCX is not particularly associated with pericytes (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1f</xref>), so the co-location of diameter reduction and blockages with pericyte somata presumably reflects pericyte process contraction rather than obstruction by eGCX.</p></sec><sec id="s2-3"><title>Pericytes constrict peritubular cortical capillaries in vivo after ischaemia and reperfusion</title><p>Two-photon microscopy in vivo, of mice expressing dsRed in pericytes, revealed peritubular cortical pericytes constricting and blocking capillaries after ischaemia and reperfusion (<xref ref-type="fig" rid="fig5">Figure 5a–c</xref>). This reduced the mean capillary diameter (averaged over all positions measured) from 10.8 ± 0.2 to 8.1 ± 0.5 µm (<italic>P</italic> &lt; 0.0001). To quantify whether ischaemia-evoked blockages occurred disproportionately close to pericytes, we measured the distance of 15 blockages to the nearest pericyte soma. This distance was 4.12 ± 0.39 µm, which is only 10% of the mean distance between peritubular cortical pericytes (41.3 ± 2.6 µm, from 103 pericyte pairs). A plot of capillary diameter versus distance from pericyte somata (<xref ref-type="fig" rid="fig5">Figure 5d</xref>) showed that ischaemia and reperfusion reduced the diameter by 40% at the somata (control 11.2 ± 0.5 vs. ischaemia 6.76 ± 1.05 µm, <italic>P</italic> = 0.001) with no significant effect on diameter far from the somata (control 10.3 ± 0.2 µm vs. ischaemia 9.6 ± 0.5 µm, <italic>P</italic> = 0.115). As in the medulla, the diameter increased significantly with distance from the pericyte somata after ischaemia (<italic>P</italic> = 0.046 comparing the slope of the best-fit regression line with zero) while in control conditions it did not (diameter decreased insignificantly with distance, <italic>P</italic> = 0.10). Thus, capillaries are constricted specifically near cortical pericytes.</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Pericytes constrict capillaries after renal ischaemia in vivo.</title><p>(<bold>a</bold>) Overview two-photon in vivo imaging stack of the mouse renal cortex microcirculation, showing pericytes expressing NG2-DsRed (red), intraluminal FITC-albumin given intravenously (green), and Hoechst 33,342 labelling nuclei (blue, 1 mg/kg in 0.5 ml of sterile, isotonic saline was administered intravenously: <xref ref-type="bibr" rid="bib19">Dunn et al., 2018</xref>). Images were acquired in a plane parallel to the cortical surface. (<bold>b, c</bold>) Higher magnification images showing apericyte on a cortical peritubular capillary in control conditions, and post-ischaemic capillary block (dashed lines show path of blocked vessel). (<bold>d</bold>) Capillary diameter versus distance from pericyte somata after ischaemia and reperfusion (I/R), and for control kidneys (CONT) (number of pericytes was 15 and 10 respectively from 10 stacks from three animals from each group). Slope of the best-fit ISCH regression line is significantly greater than zero (<italic>P</italic> = 0.046) while that of the CONT line is negative but not significantly different from zero (<italic>P</italic> = 0.10). Data are mean ± s.e.m. <italic>P</italic> values comparing data at each distance are corrected for multiple comparisons. Statistical tests used number of stacks as the N value.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Pericytes constrict capillaries after renal ischaemia in vivo.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-74211-fig5-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-74211-fig5-v2.tif"/></fig><p>The fact that pericyte constriction of capillaries reduces blood flow more in the medulla than in the cortex (<xref ref-type="fig" rid="fig1">Figure 1</xref>) may at least partly reflect differences in pericyte number and morphology in these two regions. The mean distance between pericytes in the medulla (23 μm, see above) is roughly half that in the cortex (41 μm, see above). Furthermore, in general the morphology of pericytes differs in these two regions, with DVR pericytes showing many circumferential processes around the capillaries, while cortical pericytes exhibit mainly longitudinal processes running along the capillary with only a small number of circumferential processes (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>). The small number of vessel branches in the medullary DVR implies that the class of pericyte associated with branch points that is found in the brain vasculature will be less common here.</p></sec><sec id="s2-4"><title>Rho kinase inhibition reduces pericyte constriction and no-reflow</title><p>The contractility of pericytes depends partly on Rho kinase activity (<xref ref-type="bibr" rid="bib20">Durham et al., 2014</xref>; <xref ref-type="bibr" rid="bib31">Hirunpattarasilp et al., 2019</xref>; <xref ref-type="bibr" rid="bib33">Homma et al., 2014</xref>; <xref ref-type="bibr" rid="bib45">Kutcher et al., 2007</xref>). The Rho kinase inhibitor, hydroxyfasudil (3 mg/kg; i.v.), applied at the time of reperfusion to mimic a possible therapeutic intervention, significantly inhibited the decrease of renal medullary perfusion seen after ischaemia-reperfusion (<xref ref-type="fig" rid="fig1">Figure 1a and e–f</xref>). In vivo, blood flow in the medulla (after 30 min reperfusion) was increased 3.8-fold compared to ischaemia without hydroxyfasudil (<italic>P</italic> = 0.002, <xref ref-type="fig" rid="fig1">Figure 1a</xref>). Hydroxyfasudil induced a faster recovery of medullary blood flow than BQ123 (0.5 mg/kg, i.v.), an endothelin-A receptor antagonist (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1c</xref>), but both resulted in blood flow at 30 mins reperfusion that was not significantly different from the control value (<italic>P</italic> = 0.8 and 0.38, respectively) and was significantly higher than the flow seen after ischaemia without either drug (<italic>P</italic> = 0.01 for both drugs). In contrast, the angiotensin II type 1 (AT1) receptor antagonist valsartan (1 mg/kg i.v.) speeded the initial post-ischaemic recovery of medullary blood flow, but did not return it to baseline by 30 min reperfusion (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1c</xref>). In the cortex, blood flow recovery on reperfusion was speeded by hydroxyfasudil and, after 30 min of reperfusion, was increased 1.48-fold compared to ischaemia alone (<italic>P</italic> = 0.02, <xref ref-type="fig" rid="fig1">Figure 1b</xref>).These data suggest that, in the medulla especially, activation of Rho kinase (in part downstream of ischaemia-evoked activation of endothelin-A receptors [<xref ref-type="bibr" rid="bib79">Prakash et al., 2008</xref>; <xref ref-type="bibr" rid="bib109">Wilhelm et al., 1999</xref>; <xref ref-type="bibr" rid="bib110">Yamamoto et al., 2000</xref>]) contributes to ischaemia-evoked pericyte-mediated capillary constriction.</p><p>Renal perfusion with post-ischaemic inhibition of Rho kinase was also assessedin slices of fixed kidney (see above). Treatment with hydroxyfasudil during post-ischaemic reperfusion prevented medullary no-reflow after ischaemia and reperfusion: the blood volume was increased 2.3-fold compared to ischaemia alone (<italic>P</italic> = 0.003, <xref ref-type="fig" rid="fig1">Figure 1e–f</xref>), so that it did not differ significantly from that in control kidney (<italic>P</italic> = 0.47). Hydroxyfasudil also increased ~2.9-fold the total perfused medullary capillary length (<italic>P</italic> = 0.043),~2.9 fold the number of perfused capillary segments (<italic>P</italic> = 0.02) and ~2-fold the perfused volume fraction (<italic>P</italic> = 0.0031) in medulla (<xref ref-type="fig" rid="fig2">Figure 2d–g</xref>). In the renal cortex, hydroxyfasudil given on reperfusion increased perfusion (blood volume)~1.25-fold (<italic>P</italic> = 0.0098; <xref ref-type="fig" rid="fig1">Figure 1e and g</xref>), and increased the total perfused length of capillaries, the number of perfused capillary segments and the blood volume fraction to values that were not significantly different from those in non-ischaemic kidneys (<xref ref-type="fig" rid="fig3">Figure 3c–f</xref>).</p></sec><sec id="s2-5"><title>Improvements of renal blood flow by hydroxyfasudil are via pericytes, not arterioles</title><p>Hydroxyfasudil might act on arteriolar smooth muscle or pericytes, or both. However, it had no effect on the diameter of afferent or efferent arterioles feeding and leaving the glomeruli (<xref ref-type="fig" rid="fig3">Figure 3h and i</xref>). In contrast, hydroxyfasudil reduced the constriction evoked at DVR pericyte somata by ischaemia and reperfusion, increasing the diameter from 4.5 ± 0.5 µm without hydroxyfasudil to 8.0 ± 0.4 µm with the drug (<italic>P</italic> &lt; 0.0001) (<xref ref-type="fig" rid="fig4">Figure 4g</xref>), and reduced the percentage of DVR capillaries blocked from 78 ± 9% to 8 ± 5% (<italic>P</italic> = 0.023), both of which are not significantly different from the values in non-ischaemic kidneys (<xref ref-type="fig" rid="fig4">Figure 4d and f</xref>). Thus, ischaemia induces, and hydroxyfasudil decreases, medullary no-reflow by specifically acting on DVR capillary pericytes rather than on upstream arterioles.</p></sec><sec id="s2-6"><title>Rho kinase inhibition reduces myosin light chain phosphorylation after ischaemia</title><p>Rho kinase can inhibit, either directly or by inhibiting eNOS (<xref ref-type="bibr" rid="bib85">Riddick et al., 2008</xref>; <xref ref-type="bibr" rid="bib106">Wang et al., 2009</xref>; <xref ref-type="bibr" rid="bib103">Versteilen et al., 2006</xref>), myosin light chain phosphatase (MLCP), thus increasing phosphorylation of myosin light chain (MLC) by myosin light chain kinase (MLCK) and increasing pericyte contraction, but it also has other functions. To investigate how Rho kinase inhibition has the effects described above, we labelled for phosphorylated MLC. After ischaemia and reperfusion, this was increased ~11-fold for medullary and five-fold for cortical pericytes (<italic>P</italic> = 0.0001 in both locations, <xref ref-type="fig" rid="fig6">Figure 6a–j</xref>). Hydroxyfasudil treatment after reperfusion reduced this increase so that the labelling was not significantly different from that in control kidneys (<italic>P</italic> = 0.95 and <italic>P</italic> = 0.56, respectively; <xref ref-type="fig" rid="fig6">Figure 6a–j</xref>). Thus, if pericyte contraction is via conventional smooth muscle actomyosin, the reduced MLC phosphorylation could explain the pericyte relaxation and increased blood flow evoked by Rho kinase inhibition. The data of <xref ref-type="bibr" rid="bib103">Versteilen et al., 2006</xref> suggest this is very largely mediated by inhibition of eNOS, which could be tested by quantifying the effect of eNOS block on the changes of MLC phosphorylation shown in <xref ref-type="fig" rid="fig6">Figure 6</xref>. Consistent with pericytes employing smooth muscle actomyosin, 56% of DVR pericytes near blockage sites labelled for the contractile protein α-SMA (<xref ref-type="fig" rid="fig6">Figure 6k–n</xref>; see also <xref ref-type="bibr" rid="bib74">Park et al., 1997</xref>).</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Pericyte contraction is mediated by α-SMA and regulated by Rho kinase.</title><p>Representative images of the rat renal medulla containing descending vasa recta (DVR) pericytes (<bold>a–d</bold>) and cortical peritubular capillary pericytes (<bold>f–i</bold>), labelled with antibody to phosphorylated myosin light chain (p-MLC, green), Alexa Fluor 647-isolectin B<sub>4</sub> which labels kidney tubules and pericytes (red), and DAPI which labels nuclei (blue). Labelling is shown for kidneys in control conditions (CONT) (<bold>a, f</bold>), after ischaemia and reperfusion (I/R) (<bold>b, d, g, i</bold>), and after ischaemia with hydroxyfasudil present during reperfusion (I/<italic>R</italic> + HF) (<bold>c, h</bold>). (<bold>e, j</bold>) Cortical (<bold>e</bold>) and medullary (<bold>j</bold>) p-MLC levels in pericytes for the three experimental conditions (10 stacks, 4 animals for each group). (<bold>k–m</bold>) DVR pericytes labelled for NG2 (purple), α-SMA (green), Alexa647-isolectin B4 (red) and DAPI (blue). (<bold>n</bold>) DVR blockage-associated pericyte labelled for α-SMA. Statistical tests used the numbers of animals for N values(not the stack number). Data are mean ± s.e.m. <italic>P</italic> values are corrected for multiple comparisons.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Pericyte contraction is mediated by α-SMA and regulated by Rho kinase.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-74211-fig6-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-74211-fig6-v2.tif"/></fig></sec><sec id="s2-7"><title>Rho kinase inhibitor reduces reperfusion-induced acute kidney injury</title><p>Kidney injury molecule-1 (Kim-1) is a sensitive and early diagnostic indicator of renal injury in rodent kidney injury models (<xref ref-type="bibr" rid="bib101">Vaidya et al., 2010</xref>), and in pathology is localised at high levels on the apical membrane of the proximal tubule where the tubule is most affected (<xref ref-type="bibr" rid="bib5">Amin et al., 2004</xref>; <xref ref-type="bibr" rid="bib35">Ichimura et al., 1998</xref>). Kim-1 levels in the proximal tubules were elevated 81-fold by ischaemia and reperfusion (<italic>P</italic> = 0.0004, <xref ref-type="fig" rid="fig7">Figure 7a, b and d</xref>), and treatment with hydroxyfasudil during reperfusion halved the Kim-1 labelling (<italic>P</italic> = 0.03, <xref ref-type="fig" rid="fig7">Figure 7c and d</xref>).</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Rho kinase inhibition reduces kidney injury induced by ischaemia and reperfusion.</title><p>(<bold>a–c</bold>) Images of the rat renal cortex containing proximal tubules, showing isolectin B<sub>4</sub> labelling kidney tubules (red), DAPI labelling nuclei (blue), and kidney injury molecule-1 (Kim-1) labelling as an injury marker (white lines indicate examples of injured tubules labelled in green), for control conditions (CONT) (<bold>a</bold>), after ischaemia and reperfusion (I/R) (<bold>b</bold>), and after ischaemia with hydroxyfasudil present during reperfusion (I/<italic>R</italic> + HF) (<bold>c</bold>).(<bold>d</bold>) Kim-1 levels for the three experimental conditions (six stacks, 3 animals for each group). Data are mean ± s.e.m. <italic>P</italic> values are corrected for multiple comparisons. Statistical tests used the number of animals as the N value (not the stack number).</p><p><supplementary-material id="fig7sdata1"><label>Figure 7—source data 1.</label><caption><title>Rho kinase inhibition reduces kidney injury induced by ischaemia and reperfusion.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-74211-fig7-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-74211-fig7-v2.tif"/></fig></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>This paper demonstrates, for the first time, that the long-lasting decrease of renal blood flow that follows transient ischaemia is generated by pericyte-mediated constriction and block of the descending vasa recta and cortical peritubular capillaries, as schematised in the summary of <xref ref-type="fig" rid="fig8">Figure 8</xref>, and that this post-ischaemic no-reflow can be reduced pharmacologically. We found in vivo that sites of ischaemia-evoked medullary and cortical capillary block were associated with pericyte locations. Furthermore, after ischaemia and reperfusion, the diameters of descending vasa recta and peritubular capillaries were reduced specifically near pericyte somata, which extend contractile circumferential processes around the capillaries. In contrast, cortical arteriole diameters were not reduced and glomeruli remained perfused. The fact that capillary diameters are reduced specifically near pericyte somata establishes that this is due to a contraction of the circumferential processes of pericytes, and not (for example) due to a decrease in overall perfusion pressure (which would also reduce the diameter of capillaries away from pericyte somata). Together, these data establish pericyte-mediated capillary constriction as a major therapeutic target for treating post-ischaemic renal no-reflow.</p><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>Schematic diagram of loci of blood flow reductions after renal ischaemia and reperfusion.</title><p>The afferent arteriole feeding the glomerulus (top arrow) and the efferent arteriole leaving the glomerulus are little affected by ischaemia and reperfusion. In contrast, pericytes on peritubular capillaries and the descending vasa recta (upper descending arrow) constrict the capillaries, reducing blood flow and causing blockages as schematised at the lower right, and indicated by the crossed lower descending arrow signifying impaired DVR flow. The resulting ischaemia leads to kidney damage detectable by Kim-1 labelling. Hydroxyfasudil - a Rho kinase inhibitor - reduces these effects. Created with <ext-link ext-link-type="uri" xlink:href="https://biorender.com/">https://biorender.com/</ext-link>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-74211-fig8-v2.tif"/></fig><p>Pericyte-mediated constriction of renal capillaries may reflect reduced Ca<sup>2+</sup> pumping in ischaemia, raising [Ca<sup>2+</sup>]<sub>i</sub> which activates contraction, as for CNS pericytes (<xref ref-type="bibr" rid="bib29">Hall et al., 2014</xref>). Constriction may also partly reflect a release of angiotensin II (<xref ref-type="bibr" rid="bib4">Allred et al., 2000</xref>; <xref ref-type="bibr" rid="bib8">Boer et al., 1997</xref>; <xref ref-type="bibr" rid="bib18">da Silveira et al., 2010</xref>; <xref ref-type="bibr" rid="bib65">Miyata et al., 1999</xref>; <xref ref-type="bibr" rid="bib88">Sanchez-Pozos et al., 2012</xref>; <xref ref-type="bibr" rid="bib115">Zhang et al., 2004</xref>) and endothelin-1 (<xref ref-type="bibr" rid="bib1">Afyouni et al., 2015</xref>; <xref ref-type="bibr" rid="bib37">Jones et al., 2020</xref>; <xref ref-type="bibr" rid="bib88">Sanchez-Pozos et al., 2012</xref>) which raise [Ca<sup>2+</sup>]<sub>i</sub> and Rho kinase activity (<xref ref-type="bibr" rid="bib52">Lee et al., 2014</xref>; <xref ref-type="bibr" rid="bib92">Shimokawa and Rashid, 2007</xref>), since we found that blocking endothelin-A receptors and, to a lesser extent, angiotensin II receptors improved post-ischaemic renal blood flow. Consistent with this, it has been demonstrated that vasoconstricting endothelin-A (<xref ref-type="bibr" rid="bib15">Crawford et al., 2012</xref>; <xref ref-type="bibr" rid="bib108">Wendel et al., 2006</xref>) and angiotensin II type 1 (AT1) (<xref ref-type="bibr" rid="bib15">Crawford et al., 2012</xref>; <xref ref-type="bibr" rid="bib65">Miyata et al., 1999</xref>; <xref ref-type="bibr" rid="bib99">Terada et al., 1993</xref>) receptors are located on pericytes along the descending vasa recta and regulate contractility at pericyte sites (<xref ref-type="bibr" rid="bib15">Crawford et al., 2012</xref>). Additionally, endothelin-1 and angiotensin II evoke potent vasoconstriction of the descending vasa recta mainly through endothelin-A (<xref ref-type="bibr" rid="bib93">Silldorff et al., 1995</xref>) and angiotensin II type 1 (AT1) (<xref ref-type="bibr" rid="bib84">Rhinehart et al., 2003</xref>) receptors.</p><p>It has long been known that some pericyte populations in the kidney, especially those in the descending vasa recta, express α-SMA and regulate capillary blood flow (<xref ref-type="bibr" rid="bib74">Park et al., 1997</xref>; <xref ref-type="bibr" rid="bib90">Shaw et al., 2018</xref>), presumably via actomyosin-based contractility. A potentially important physiological role for the presence of α-SMA in the descending vasa recta pericytes is the ability of these pericytes to regulate blood flow distribution within the renal medulla (<xref ref-type="bibr" rid="bib72">Pallone and Silldorff, 2001</xref>; <xref ref-type="bibr" rid="bib74">Park et al., 1997</xref>). In cerebral, retinal and cardiac pericytes, demonstrating pericyte α-SMA labelling has been difficult, but a more favourable fixative might increase the percentage of cells labelled (<xref ref-type="bibr" rid="bib2">Alarcon-Martinez et al., 2018</xref>). In agreement with other studies, we observed that α-SMA protein was strongly labelled within the pericytes surrounding the descending vasa recta (<xref ref-type="fig" rid="fig6">Figure 6k–n</xref>; see also <xref ref-type="bibr" rid="bib74">Park et al., 1997</xref>), including in pericytes near ischaemia-evoked blockage sites. Pericyte-specific deletion of α-SMA would allow assessment of whether this is the actin isoform conferring pericyte contractility (cf. <xref ref-type="bibr" rid="bib3">Alarcon-Martinez et al., 2019</xref>). Furthermore, ischaemia increased MLC phosphorylation in pericytes (<xref ref-type="fig" rid="fig6">Figure 6a–j</xref>) and led to pericyte-mediated capillary constriction, consistent with actomyosin mediating the contractility of these cells.</p><p>Rho kinase, a key downstream effector of both endothelin-1 and angiotensin II, inhibits the MLC dephosphorylation required to relax pericytes (<xref ref-type="bibr" rid="bib41">Kimura et al., 1996</xref>; <xref ref-type="bibr" rid="bib58">Maeda et al., 2003</xref>), mainly by inhibiting eNOS activity (<xref ref-type="bibr" rid="bib103">Versteilen et al., 2006</xref>),thus promoting constriction (<xref ref-type="bibr" rid="bib30">Hartmann et al., 2021</xref>). Rho kinase also promotes actin polymerisation (<xref ref-type="bibr" rid="bib46">Kutcher and Herman, 2009</xref>; <xref ref-type="bibr" rid="bib59">Maekawa et al., 1999</xref>; <xref ref-type="bibr" rid="bib116">Zhang et al., 2018a</xref>). We found that blocking Rho kinase with hydroxyfasudil reduced MLC phosphorylation in pericytes after ischaemia (<xref ref-type="fig" rid="fig6">Figure 6a–j</xref>), and reversed ischaemia-evoked pericyte-mediated capillary constriction (hydroxyfasudil increased the capillary diameter specifically at pericyte somata (<xref ref-type="fig" rid="fig4">Figure 4g</xref>) in ischaemic animals, implying that the effects of Rho kinase inhibition were on renal pericytes rather than an extra-renal systemic action). This could explain why Rho kinase block reduces acute kidney injury (<xref ref-type="bibr" rid="bib39">Kentrup et al., 2011</xref>; <xref ref-type="bibr" rid="bib79">Prakash et al., 2008</xref>; <xref ref-type="bibr" rid="bib100">Teraishi et al., 2004</xref>; <xref ref-type="bibr" rid="bib104">Versteilen et al., 2011</xref>; <xref ref-type="bibr" rid="bib103">Versteilen et al., 2006</xref>), as we have confirmed using kidney injury molecule-1 (Kim-1) as a marker (<xref ref-type="fig" rid="fig7">Figure 7c and d</xref>). In addition to inhibiting pericyte-mediated capillary constriction, hydroxyfasudil may also reduce kidney injury by reducing microvascular leukocyte accumulation, possibly by increasing the activity of eNOS (<xref ref-type="bibr" rid="bib104">Versteilen et al., 2011</xref>; <xref ref-type="bibr" rid="bib112">Yamasowa et al., 2005</xref>). It will be of interest to assess the efficacy of Rho kinase block for preventing kidney injury after longer periods of ischaemia than the 1 hr that we employed. In agreement with our findings in kidney pericytes, Rho kinase inhibition can block optogenetically induced constriction of brain capillaries by pericytes (<xref ref-type="bibr" rid="bib30">Hartmann et al., 2021</xref>). Taken together, these findings support the concept that ischaemia-evoked capillary constriction reflects renal pericytes generating an actomyosin-dependent contraction, rather than there being a non-specific mechanism of constriction such as pericyte swelling.</p><p>Hydroxyfasudil is the active metabolite of fasudil, a drug that has been clinically approved in Japan since 1995 for the treatment of vasospasm following subarachnoid haemorrhage (<xref ref-type="bibr" rid="bib55">Lingor et al., 2019</xref>). Fasudil treatment improves stroke outcome in animal models (<xref ref-type="bibr" rid="bib105">Vesterinen et al., 2013</xref>) and humans (<xref ref-type="bibr" rid="bib91">Shibuya et al., 2005</xref>) and our data suggest that it may also be useful for reducing post-ischaemic renal no-reflow and kidney damage.</p><p>We considered possible non-pericyte explanations for post-ischaemic capillary constriction and block. Post-ischaemic erythrocyte congestion in vasa recta has previously been described (<xref ref-type="bibr" rid="bib16">Crislip et al., 2017</xref>; <xref ref-type="bibr" rid="bib70">Olof et al., 1991</xref>) however physically adhering red blood cells do not physically cause the capillary blockages observed after ischaemia as they were associated with only a small percentage of block sites (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1a, b</xref>). Thus, red blood cell trapping could be a consequence rather than a cause of the blockages. However, we cannot rule out the possibility that we observed only a small percentage of red blood cells in the capillary lumen because they are more readily displaced during the perfusion with PBS and PFA followed by FITC-albumin in gelatin than with protocols that do not perform transcardial perfusion or perform it only once (<xref ref-type="bibr" rid="bib28">Gaudin et al., 2014</xref>; <xref ref-type="bibr" rid="bib113">Yemisci et al., 2009</xref>). Leukocyte trapping may also contribute to reducing blood flow, but occurs on a longer time scale than we have studied (<xref ref-type="bibr" rid="bib38">Kelly et al., 1994</xref>; <xref ref-type="bibr" rid="bib80">Rabb et al., 1995</xref>; <xref ref-type="bibr" rid="bib114">Ysebaert et al., 2000</xref>). Similarly, although a degradation of the eGCX has been reported after ischaemia (<xref ref-type="bibr" rid="bib94">Snoeijs et al., 2010</xref>; <xref ref-type="bibr" rid="bib96">Song et al., 2018</xref>), we found a uniform distribution of the eGCX along the vessel wall, which was not modified after ischaemia (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1e, h</xref>), thus ruling out a causal association with capillary blockages which are preferentially located near pericytes. The present study demonstrates that pericyte-mediated constrictions of the descending vasa recta and cortical peritubular capillaries contribute to no-reflow and kidney injury at early stages of reperfusion; however, we cannot exclude the possibility that other factors, such as inflammation and leukocyte infiltration (<xref ref-type="bibr" rid="bib27">Gandolfo et al., 2009</xref>; <xref ref-type="bibr" rid="bib38">Kelly et al., 1994</xref>; <xref ref-type="bibr" rid="bib80">Rabb et al., 1995</xref>; <xref ref-type="bibr" rid="bib114">Ysebaert et al., 2000</xref>), or eGCX dysfunction (<xref ref-type="bibr" rid="bib9">Bongoni et al., 2019</xref>), might also contribute to post-ischaemic microvascular injury at later phases of acute kidney injury. Furthermore, in response to the pericyte-mediated constriction evoked by ischaemia, the DVR may undergo post-ischaemic adaptations, releasing more nitric oxide at 48 hr post-ischaemia which could reduce pericyte constriction at later times after ischaemia than we have studied (<xref ref-type="bibr" rid="bib117">Zhang et al., 2018b</xref>).</p><p>The recovery of blood flow in the medulla on renal arterial reperfusion was slower than in the cortex. The regulation of renal medullary blood flow is mainly mediated by vasa recta pericytes, independent of total or cortical blood flow (<xref ref-type="bibr" rid="bib72">Pallone and Silldorff, 2001</xref>). The need for accurate flow regulation in the relatively hypoxic medulla may account for pericytes on the DVR being much closer together (mean separation 22.9 ± 0.9 µm) and with more circumferential processes (<xref ref-type="fig" rid="fig4">Figure 4a–c</xref>, <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2b</xref>) than for peritubular cortical pericytes (mean separation 41.3 ± 2.6 µm) which have mainly longitudinal (strand-like) processes (<xref ref-type="fig" rid="fig5">Figure 5a–c</xref>, <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2a</xref>) and this may, in turn, contribute to a greater pericyte-mediated restriction of blood flow after ischaemia in the DVR than in the cortical capillaries. Despite these morphological differences between cortical and medullary pericytes, they showed similar immunoreactivity changes for p-MLC after ischaemia/reperfusion and hydroxyfasudil treatment (<xref ref-type="fig" rid="fig6">Figure 6a–j</xref>). Perhaps surprisingly, given our data, in post-cadaveric renal transplants a better outcome has been reported for kidneys with a higher number of pericytes immediately post-transplant (<xref ref-type="bibr" rid="bib48">Kwon et al., 2008</xref>). This may, however, reflect an aspect of pericyte function other than capillary constriction, such as angiogenesis and maintenance of vessel integrity (<xref ref-type="bibr" rid="bib90">Shaw et al., 2018</xref>), with these functions failing in transplanted tissue in which pericytes have already died due to ischaemia.</p><p>In the brain, heart, and retina, contractile pericytes on capillaries play a key role in producing a prolonged reduction of blood flow after ischaemia (<xref ref-type="bibr" rid="bib29">Hall et al., 2014</xref>; <xref ref-type="bibr" rid="bib71">O’Farrell et al., 2017</xref>; <xref ref-type="bibr" rid="bib113">Yemisci et al., 2009</xref>). Depending on the type of ischaemic model applied to these organs, collateral vessels may allow some (reduced) blood flow after the onset of ischaemia, which would lead to variable organ damage (<xref ref-type="bibr" rid="bib23">Farkas et al., 2007</xref>; <xref ref-type="bibr" rid="bib56">Liu et al., 2019</xref>; <xref ref-type="bibr" rid="bib63">Minhas et al., 2012</xref>). In contrast, the kidney largely depends on the renal artery to provide a non-anastomotic supply to the glomeruli of each nephro-vascular unit (<xref ref-type="bibr" rid="bib22">Evans et al., 2013</xref>; <xref ref-type="bibr" rid="bib73">Pallone et al., 2012</xref>). Medullary hypoxia under normal conditions has been documented in several mammalian species, including humans (<xref ref-type="bibr" rid="bib21">Epstein et al., 1982</xref>; <xref ref-type="bibr" rid="bib53">Leonhardt and Landes, 1963</xref>). The medullary partial pressure of oxygen is ~10–20 mm Hg, contrasting with the partial pressure of oxygen in the cortex, which is ~50 mm Hg (<xref ref-type="bibr" rid="bib12">Brezis et al., 1994a</xref>; <xref ref-type="bibr" rid="bib11">Brezis et al., 1991</xref>; <xref ref-type="bibr" rid="bib13">Brezis et al., 1994b</xref>). Thus, renal pericytes, especially in the medulla, are likely to be more susceptible to ischaemic injury than in other organs.</p><p>Rodent models of renal ischaemia can employ bilateral ischaemia or unilateral ischaemia with or without contralateral nephrectomy (<xref ref-type="bibr" rid="bib25">Fu et al., 2018</xref>). In the present study, unilateral ischaemia without contralateral nephrectomy (which may occur during renal-sparing surgeries) (<xref ref-type="bibr" rid="bib32">Hollenbeck et al., 2006</xref>; <xref ref-type="bibr" rid="bib61">Medina-Rico et al., 2017</xref>) was chosen to explore the early mechanisms of ischaemia and reperfusion injury while using the contralateral kidney as a paired control for potential systemic haemodynamic changes that could be triggered during and after the surgical procedure. The presence of an uninjured contralateral kidney reduces animal mortality during the surgical procedure, and thus longer ischaemia times can be used, resulting in more severe and reproducible injury (<xref ref-type="bibr" rid="bib25">Fu et al., 2018</xref>; <xref ref-type="bibr" rid="bib51">Le Clef et al., 2016</xref>; <xref ref-type="bibr" rid="bib77">Polichnowski et al., 2020</xref>; <xref ref-type="bibr" rid="bib97">Soranno et al., 2019</xref>). Unilateral ischaemia-reperfusion without contralateral nephrectomy is considered a strong model to study the progression from acute renal injury to long-term tubulo-interstitial fibrosis (<xref ref-type="bibr" rid="bib25">Fu et al., 2018</xref>; <xref ref-type="bibr" rid="bib51">Le Clef et al., 2016</xref>; <xref ref-type="bibr" rid="bib77">Polichnowski et al., 2020</xref>; <xref ref-type="bibr" rid="bib97">Soranno et al., 2019</xref>), but we acknowledge that the model used in the present study may not be similar to some clinical situations where both kidneys are injured, and there are limitations of translatability from all animal models of acute kidney injury to human disease (<xref ref-type="bibr" rid="bib25">Fu et al., 2018</xref>). A limitation of our study is that all experiments were performed on male rats and mice. Female rats are relatively protected against post-ischaemic renal failure (<xref ref-type="bibr" rid="bib54">Lima-Posada et al., 2017</xref>; <xref ref-type="bibr" rid="bib66">Müller et al., 2002</xref>), possibly because in male rats androgens promote ischaemic kidney damage by triggering endothelin-induced vascular constriction (<xref ref-type="bibr" rid="bib66">Müller et al., 2002</xref>). However, these studies showed that sex did not influence ischaemia repefusion-induced injury after 24 hr, but only after 7 days (<xref ref-type="bibr" rid="bib54">Lima-Posada et al., 2017</xref>; <xref ref-type="bibr" rid="bib66">Müller et al., 2002</xref>), which is on a much longer time scale than we have studied.</p><p>In the present study, we have shown that pericyte contraction contributes to reducing cortical and medullary blood flow at early stages of reperfusion. This initial pattern could also contribute to the pericyte injury, detachment and capillary rarefaction observed at later stages after ischaemia and reperfusion (<xref ref-type="bibr" rid="bib42">Kramann et al., 2017</xref>), which lead to further damage to the kidney (<xref ref-type="bibr" rid="bib40">Khairoun et al., 2013</xref>; <xref ref-type="bibr" rid="bib42">Kramann et al., 2017</xref>). However, there was no evidence of pericyte detachment during the time frame of the present study. Treatment from the beginning of reperfusion (to mimic a clinically possible therapeutic approach) with hydroxyfasudil, a Rho kinase inhibitor, increased medullary and cortical blood flow, increased the post-ischaemic diameter of DVR capillaries at pericyte locations, reduced the percentage of DVR capillaries that remained blocked, and reduced kidney injury after renal reperfusion. Presumably, the protection of renal blood flow and downstream tissue health would be even greater if hydroxyfasudil could be given before ischaemia was induced (e.g. in situations such as cardiac surgery and kidney transplantation, where renal ischaemia might be anticipated). Thus, pericytes are a novel therapeutic target for reducing no-reflow after renal ischaemia. Acute kidney injury caused by post-ischaemic no-reflow causes significant socio-economic cost. Our identification ofpericyte contraction as a therapeutic target for ischaemia-induced acute kidney injury should contribute to the development or re-purposing of drugs that can prevent renal no-reflow.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Strain, strain background<italic>Rattusnorvegicus</italic> (Sprague Dawley, male)</td><td align="left" valign="bottom">Rat</td><td align="left" valign="bottom">UCL Biological Services</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus/spretus</italic>, male)</td><td align="left" valign="bottom">NG2-DsRed mice</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1242/dev.004895">https://doi.org/10.1242/dev.004895</ext-link></td><td align="left" valign="bottom">JAX 008241</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-NG2 (mouse monoclonal)</td><td align="left" valign="bottom">AbCam</td><td align="left" valign="bottom">ab50009</td><td align="char" char="." valign="bottom">(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Myosin light chain (phospho S20) (rabbit polyclonal)</td><td align="left" valign="bottom">AbCam</td><td align="left" valign="bottom">ab5694</td><td align="char" char="." valign="bottom">(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">kidney injury molecule-1 (Kim-1) (rabbit polyclonal)</td><td align="left" valign="bottom">NovusBiologicals</td><td align="left" valign="bottom">NBP1-76701</td><td align="char" char="." valign="bottom">(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-alpha smooth muscle actin (rabbit polyclonal)</td><td align="left" valign="bottom">AbCam</td><td align="left" valign="bottom">ab5694</td><td align="char" char="." valign="bottom">(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-glycophorin A (mouse monoclonal)</td><td align="left" valign="bottom">AbCam</td><td align="left" valign="bottom">ab9520</td><td align="char" char="." valign="bottom">(1:2000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa Fluor 405 goat anti-rabbit (polyclonal)</td><td align="left" valign="bottom">ThermoFisher</td><td align="left" valign="bottom">A31556</td><td align="char" char="." valign="bottom">(1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa Fluor 555 donkey anti-rabbit (polyclonal)</td><td align="left" valign="bottom">ThermoFisher</td><td align="left" valign="bottom">A31572</td><td align="char" char="." valign="bottom">(1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa Fluor 555 donkey anti-mouse (polyclonal)</td><td align="left" valign="bottom">ThermoFisher</td><td align="left" valign="bottom">A31570</td><td align="char" char="." valign="bottom">(1:500)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">isolectin B<sub>4</sub> - AlexaFluor 647</td><td align="left" valign="bottom">ThermoFisher</td><td align="left" valign="bottom">I32450</td><td align="char" char="." valign="bottom">(1:200)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">wheat germ agglutinin Alexa Fluor 647 conjugate</td><td align="left" valign="bottom">ThermoFisher</td><td align="left" valign="bottom">W32466</td><td align="left" valign="bottom">200 μl (1 mg/ml)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Hoechst 33,342</td><td align="left" valign="bottom">ThermoFisher</td><td align="left" valign="bottom">H21492</td><td align="left" valign="bottom">1 mg/kg in 0.5 ml saline</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">gelatin</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">G2625</td><td align="char" char="." valign="bottom">5% in PBS</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">FITC-albumin</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">A9771</td><td align="char" char="." valign="bottom">1:200 in 5% gelatin</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">FITC-albumin</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">A9771</td><td align="left" valign="bottom">(1 mg in 100 μl; i.v.)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Hydroxyfasudilhydrochloride</td><td align="left" valign="bottom">Santa Cruz Biotechnology</td><td align="left" valign="bottom">sc-202176</td><td align="left" valign="bottom">(3 mg/kg; i.v.)</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom"><italic>MATLAB R2015a</italic></td><td align="left" valign="bottom">MathWorks, Inc.</td><td align="left" valign="bottom"/><td align="left" valign="bottom">in vivo data acquisition</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">ImageJ</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://imagej.nih.gov/ij/">https://imagej.nih.gov/ij/</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">imageanalysis</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">GraphPadPrism 6</td><td align="left" valign="bottom">GraphPad Software, Inc</td><td align="left" valign="bottom"/><td align="left" valign="bottom">statisticalanalysis</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">DAPI stain</td><td align="left" valign="bottom">Molecular Probes</td><td align="left" valign="bottom">D1306</td><td align="left" valign="bottom">200 μl (5 μg/ml)</td></tr></tbody></table></table-wrap><sec id="s4-1"><title>Study approval</title><p>Experiments were performed in accordance with European Commission Directive 2010/63/EU and the UK Animals (Scientific Procedures) Act (1986), with approval from the UCL Animal Welfare and Ethical Review Body.</p></sec><sec id="s4-2"><title>Animal preparation for ischaemia experiments</title><p>Due to the high density of kidney tissue, intravital microscopy is limited to superficial regions of the cortex &lt;100 μm deep (<xref ref-type="bibr" rid="bib89">Sandoval and Molitoris, 2017</xref>). As the renal medulla is inaccessible for in vivo imaging, we used laser Doppler flowmetry to assess blood flow changes of both kidneys or within the cortex and medulla of one kidney simultaneously. Additionally, we used FITC-albumin gelatin perfusion for measuring microvascular network perfusion (<xref ref-type="bibr" rid="bib71">O’Farrell et al., 2017</xref>) in the renal cortex and medulla, supplemented with high-resolution images of individual capillaries to assess the mechanisms underlying blood flow changes.</p><p>Adult male Sprague-Dawley rats (P40-50), or NG2-dsRed male mice (P100-120) expressing dsRed in pericytes to allow live pericyte imaging, were anesthetized with pentobarbital sodium (induction 60 mg/kg i.p.; maintenance 10–15 mg/kg/h i.v.). The femoral veins were cannulated to administer anesthetic and drugs. Stable kidney perfusion was confirmed using laser Doppler probes (OxyFlo Pro 2-channel laser Doppler, Oxford, United Kingdom) to measure blood flow in the contralateral kidney throughout the experiment, and anesthesia was monitored by the absence of a withdrawal response to a paw pinch. Body temperature was maintained at 37.0°C ± 0.5°C with a heating pad.</p></sec><sec id="s4-3"><title>Renal ischaemia and reperfusion</title><p>Both kidneys were exposed, and the renal arteries and veins were dissected. Left kidneys were subjected to 60 min ischaemia by renal artery and vein cross-clamp, followed by 30 or 60 min reperfusion. This reperfusion duration was chosen to assess pericyte function soon after starting reperfusion. Right kidneys underwent the same procedures without vessel clamping. Two laser Doppler single-fibre implantable probes of 0.5 mm diameter (MSF100NX, Oxford Optronix, Oxford, United Kingdom) measured simultaneously the perfusion of both kidneys (or of the outer medulla and cortex of one kidney). Cortical and outer medullary perfusion were measured with the probe on or 2 mm below the kidney surface, respectively. Successful artery and vein occlusion was confirmed by a sudden fall of laser Doppler signal. Laser Doppler monitoring, which detects the movement of cells in the blood, is a widely used method for studies of microvascular perfusion in experimental and clinical studies and measures the total local microcirculatory blood perfusion in capillaries, arterioles, venules and shunting vessels (<xref ref-type="bibr" rid="bib24">Fredriksson et al., 2009</xref>; <xref ref-type="bibr" rid="bib81">Rajan et al., 2008</xref>). Laser Doppler is suitable for monitoring of relative renal microvascular blood flow changes in response to physiological and pharmacological stimuli in rodents (<xref ref-type="bibr" rid="bib57">Lu et al., 1993</xref>; <xref ref-type="bibr" rid="bib102">Vassileva et al., 2003</xref>).</p><p>Endothelial glycocalyx (eGCX) was labelled in vivo using wheat germ agglutinin (WGA) Alexa Fluor 647 conjugate (ThermoFisher, W32466, Waltham, MA) injected through the jugular vein (200 μl, 1 mg/ml) 45 min before renal ischaemia/reperfusion (<xref ref-type="bibr" rid="bib47">Kutuzov et al., 2018</xref>). WGA binds to N-acetyl-D-glucosamine and sialic acid residues of the eGCX. Using ImageJ, WGA fluorescence intensities were measured by drawing regions of interest (ROIs) across capillaries at the mid-points of pericyte somata, and away from the soma in 5 μm increments on both sides of the pericyte. Capillary diameters were also measured at each position.</p><p>Hydroxyfasudil hydrochloride, a reversible cell-permeable inhibitor of Rho kinase (Santa Cruz Biotechnology sc-202176, Dallas, TX) which is expected to decrease pericyte contractility (<xref ref-type="bibr" rid="bib30">Hartmann et al., 2021</xref>; <xref ref-type="bibr" rid="bib45">Kutcher et al., 2007</xref>) was administered as a bolus (3 mg/kg <italic>i.v</italic>.), immediately on starting reperfusion. This protocol, rather than having the drug present during the ischaemic insult, better mimics a clinical situation where drugs could be given on reperfusion. Control and non-treated ischaemic animals received saline infusion with the same volume.</p></sec><sec id="s4-4"><title>Animal perfusion and tissue preparation for imaging</title><p>After renal ischaemia/reperfusion, animals were overdosed with pentobarbital sodium and transcardially-perfused with phosphate-buffered saline (PBS) (200 ml) followed by 4% paraformaldehyde (PFA, 200 ml) fixative and then 5% gelatin (20 ml in PBS Sigma-Aldrich, G2625, Darmstadt, Germany) solution containing FITC-albumin (Sigma-Aldrich, A9771, Darmstadt, Germany), followed by immersion in ice for 30 min (adapted from <xref ref-type="bibr" rid="bib7">Blinder et al., 2013</xref>). Kidneys were fixed overnight in 4% PFA, and 150 µm longitudinal sections made for immunohistochemistry. Rats have ~64 ml of blood per kg bodyweight, thus the FITC-albumin gelatin solution would suffice to fill the total blood volume. The gelatin sets when the body temperature falls and traps FITC-albumin in the perfused vessels; blocked vessels show no penetration of FITC-albumin past the block.</p></sec><sec id="s4-5"><title>In vivo two-photon imaging</title><p>NG2-DsRed mice (P100-120) were anesthetized using urethane (1.55 g/kg i.p., in two doses 15 min apart). Anesthesia was confirmed by the absence of a paw pinch withdrawal response. Body temperature was maintained at 36.8°C ± 0.3°C. A custom-built plate, attached to the kidney using superglue and agarose created a sealed well filled with phosphate-buffered saline during imaging, when the plate was secured under the objective on a custom-built stage.</p><p>Peritubular capillary diameter was recorded during renal ischaemia/reperfusion using two-photon microscopy of the intraluminal FITC-albumin (1 mg in 100 μl of saline given intravenously). Two-photon excitation used a Newport-Spectra Physics Mai Tai Ti:Sapphire Laser pulsing at 80 MHz, and a (Zeiss LSM710, Oberkochen, Germany) microscope with a 20 × water immersion objective (NA 1.0). Fluorescence was excited using 920 nm wavelength for DsRed, and 820 nm for FITC-albumin and Hoechst 33,342. Mean laser power under the objective was &lt;35 mW. Images were analysed using ImageJ. Vessel diameter was defined using a line drawn across the vessel as the width of the intraluminal dye fluorescence.</p></sec><sec id="s4-6"><title>Immunohistochemistry</title><p>Pericytes were labelled by expression of DsRed under control of the NG2 promoter (in mice), or with antibodies to NG2 (1:200; Abcam ab50009, Cambridge, United Kingdom), α-smooth muscle actin (α-SMA) (1:100; Abcam ab5694, Cambridge, United Kingdom), or myosin light chain (phospho S20, 1:100, Abcam ab2480, Cambridge, United Kingdom), and the capillary basement membrane and pericytes were labelledwith isolectin B<sub>4</sub>-Alexa Fluor 647 (1:200, overnight; Molecular Probes, I32450, Thermo Fisher Scientific, Waltham, MA). Z-stacks of the cortex and outer medulla (frame size 640.17 × 640.17 µm) for cell counting were acquired confocally (Zeiss LSM 700, Oberkochen, Germany). Pericyte intersoma distance was calculated between pairs of pericytes on capillaries within the same imaging plane. Kidney damage was assessed using kidney injury molecule-1 (Kim-1) antibody (1:100, overnight; Novus Biologicals, NBP1-76701, Abingdon, United Kingdom). Red blood cells were labelled with antibody to glycophorin A (1:2000, AbCam ab9520, Cambridge, United Kingdom). Alexa Fluor conjugated secondary antibodies were added overnight (1:500; ThermoFisher, A31572, A31556, A31570, Waltham, MA).</p></sec><sec id="s4-7"><title>Image analysis</title><p>Regions of interest (ROIs) were drawn around the renal cortex and medulla (<xref ref-type="fig" rid="fig1">Figure 1</xref>). The cortex thickness, which ranges from 1.5 mm to 3 mm in rodents, was defined as the distance from the renal surface (capsule) to the base of the medullar pyramid (<xref ref-type="bibr" rid="bib6">Andersen et al., 2020</xref>; <xref ref-type="bibr" rid="bib64">Missbach-Guentner et al., 2018</xref>; <xref ref-type="bibr" rid="bib68">Nogueira et al., 2016</xref>). The FITC-albumin perfusion coupled with image threshold application also helped to visualise the cortical vessels and medullary rays in order to define the corticomedullary boundary.The mean FITC-albumin signal intensity was measured for each ROI using ImageJ. This signal is assumed to provide an approximate measure of the amount of blood perfusing the tissue (conceivably downstream capillary constriction could lead to an upstream dilation and an increased blood volume being detected but, if this did occur, it would lead to an underestimate of the decrease of perfusion occurring). To gain a more accurate assessment of perfusion, we also used the ImageJ macro TubeAnalyst (Advanced Digital Microscopy Core Facility at IRB Barcelona) to measure the microvascular network ‘skeleton’ of the renal cortex and medulla and obtain the total perfused capillary length, the number of perfused capillary segments and the overall perfused microvascular volume fraction (<xref ref-type="fig" rid="fig2">Figure 2b–d</xref>). To quantify the percentage of perfused capillaries, we counted the number of filled (with FITC-albumin) and unfilled vessels that crossed a line drawn through the centre of each image perpendicular to the main capillary axis.</p><p>To assess whether pericytes cause flow blockages, we measured the distance along the capillary from the termination of the FITC-albumin signal to the mid-point of the nearest visible pericyte soma, since in brain most contractile circumferential pericyte processes (which can adjust capillary diameter) are near the pericyte soma (see <xref ref-type="fig" rid="fig4">Figures 4d</xref> and <xref ref-type="fig" rid="fig5">5f</xref>, S2 and S3 of <xref ref-type="bibr" rid="bib69">Nortley et al., 2019</xref>). Capillary diameters were measured at the block sites where the FITC-albumin signal terminated. We also plotted the diameter of the FITC-albumin labelled capillary lumen as a function of the distance from the pericyte somata to assess whether diameter reduction was a nonspecific effect of ischaemia, or was pericyte-related. A constriction seen specifically at pericyte somata is an unambiguous indication that pericyte contraction is occurring (<xref ref-type="bibr" rid="bib69">Nortley et al., 2019</xref>). The identification, and direction of flow, of the afferent and efferent arterioles were deduced from tracking in confocal Z-stacks.</p><p>For quantification of the p-MLC levels in cortical and medullary pericytes, we selected regions of interest (ROIs) over pericytes after applying to maximum intensity projected stack images a lower and upper threshold, which was similar for all experimental groups (typically 50–150 in 8-bit images). Then, we used the ROIs thus selected to measure the mean fluorescence intensity over all the pericytes in each image. The background signal for each stack was obtained by placing a ROI in the parenchyma, away from but close to, the pericytes and the measured background fluorescence signal was subtracted from the mean intensity measured in the pericyte ROIs.</p></sec><sec id="s4-8"><title>Statistics</title><p>Statistical analysis employed Graphpad Prism (San Diego, CA). Data normality was tested with Shapiro-Wilk tests. Normally distributed data were compared using Student’s 2-tailed t-tests or ANOVA tests. Data that were not normally distributed were analysed with Mann-Whitney or Kruskal-Wallis tests. <italic>P</italic> values were corrected for multiple comparisons using a procedure equivalent to the Holm-Bonferroni method or Dunn’s test (corrected <italic>P</italic> values are significant if they are less than 0.05).</p></sec></sec></body><back><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Supervision, Validation, Visualization, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Funding acquisition, Project administration, Resources, Supervision, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Experiments were performed under UK government Home Office licence 70/8976 in accordance with European Commission Directive 2010/63/EU and the UK Animals (Scientific Procedures) Act (1986), with approval from the UCL Animal Welfare and Ethical Review Body.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-74211-transrepform1-v2.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting file.</p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank Jonathan Lezmy, Svetlana Mastitskaya and Thomas Pfeiffer for comments on the manuscript.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Afyouni</surname><given-names>NE</given-names></name><name><surname>Halili</surname><given-names>H</given-names></name><name><surname>Moslemi</surname><given-names>F</given-names></name><name><surname>Nematbakhsh</surname><given-names>M</given-names></name><name><surname>Talebi</surname><given-names>A</given-names></name><name><surname>Shirdavani</surname><given-names>S</given-names></name><name><surname>Maleki</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Preventive Role of Endothelin Antagonist on Kidney Ischemia: Reperfusion Injury in Male and Female Rats</article-title><source>International Journal of Preventive Medicine</source><volume>6</volume><elocation-id>128</elocation-id><pub-id pub-id-type="doi">10.4103/2008-7802.172549</pub-id><pub-id pub-id-type="pmid">26900442</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alarcon-Martinez</surname><given-names>L</given-names></name><name><surname>Yilmaz-Ozcan</surname><given-names>S</given-names></name><name><surname>Yemisci</surname><given-names>M</given-names></name><name><surname>Schallek</surname><given-names>J</given-names></name><name><surname>Kılıç</surname><given-names>K</given-names></name><name><surname>Can</surname><given-names>A</given-names></name><name><surname>Di Polo</surname><given-names>A</given-names></name><name><surname>Dalkara</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Capillary pericytes express α-smooth muscle actin, which requires prevention of filamentous-actin depolymerization for detection</article-title><source>eLife</source><volume>7</volume><elocation-id>34861</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.34861</pub-id><pub-id pub-id-type="pmid">29561727</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alarcon-Martinez</surname><given-names>L</given-names></name><name><surname>Yilmaz-Ozcan</surname><given-names>S</given-names></name><name><surname>Yemisci</surname><given-names>M</given-names></name><name><surname>Schallek</surname><given-names>J</given-names></name><name><surname>Kılıç</surname><given-names>K</given-names></name><name><surname>Villafranca-Baughman</surname><given-names>D</given-names></name><name><surname>Can</surname><given-names>A</given-names></name><name><surname>Di Polo</surname><given-names>A</given-names></name><name><surname>Dalkara</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Retinal ischemia induces α-SMA-mediated capillary pericyte contraction coincident with perivascular glycogen depletion</article-title><source>Acta Neuropathologica Communications</source><volume>7</volume><elocation-id>134</elocation-id><pub-id pub-id-type="doi">10.1186/s40478-019-0761-z</pub-id><pub-id pub-id-type="pmid">31429795</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allred</surname><given-names>AJ</given-names></name><name><surname>Chappell</surname><given-names>MC</given-names></name><name><surname>Ferrario</surname><given-names>CM</given-names></name><name><surname>Diz</surname><given-names>DI</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Differential actions of renal ischemic injury on the intrarenal angiotensin system</article-title><source>American Journal of Physiology-Renal Physiology</source><volume>279</volume><fpage>F636</fpage><lpage>F645</lpage><pub-id pub-id-type="doi">10.1152/ajprenal.2000.279.4.F636</pub-id><pub-id pub-id-type="pmid">10997913</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amin</surname><given-names>RP</given-names></name><name><surname>Vickers</surname><given-names>AE</given-names></name><name><surname>Sistare</surname><given-names>F</given-names></name><name><surname>Thompson</surname><given-names>KL</given-names></name><name><surname>Roman</surname><given-names>RJ</given-names></name><name><surname>Lawton</surname><given-names>M</given-names></name><name><surname>Kramer</surname><given-names>J</given-names></name><name><surname>Hamadeh</surname><given-names>HK</given-names></name><name><surname>Collins</surname><given-names>J</given-names></name><name><surname>Grissom</surname><given-names>S</given-names></name><name><surname>Bennett</surname><given-names>L</given-names></name><name><surname>Tucker</surname><given-names>CJ</given-names></name><name><surname>Wild</surname><given-names>S</given-names></name><name><surname>Kind</surname><given-names>C</given-names></name><name><surname>Oreffo</surname><given-names>V</given-names></name><name><surname>Davis</surname><given-names>JW</given-names></name><name><surname>Curtiss</surname><given-names>S</given-names></name><name><surname>Naciff</surname><given-names>JM</given-names></name><name><surname>Cunningham</surname><given-names>M</given-names></name><name><surname>Tennant</surname><given-names>R</given-names></name><name><surname>Stevens</surname><given-names>J</given-names></name><name><surname>Car</surname><given-names>B</given-names></name><name><surname>Bertram</surname><given-names>TA</given-names></name><name><surname>Afshari</surname><given-names>CA</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Identification of putative gene based markers of renal toxicity</article-title><source>Environmental Health Perspectives</source><volume>112</volume><fpage>465</fpage><lpage>479</lpage><pub-id pub-id-type="doi">10.1289/ehp.6683</pub-id><pub-id pub-id-type="pmid">15033597</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>SB</given-names></name><name><surname>Taghavi</surname><given-names>I</given-names></name><name><surname>Hoyos</surname><given-names>CAV</given-names></name><name><surname>Søgaard</surname><given-names>SB</given-names></name><name><surname>Gran</surname><given-names>F</given-names></name><name><surname>Lönn</surname><given-names>L</given-names></name><name><surname>Hansen</surname><given-names>KL</given-names></name><name><surname>Jensen</surname><given-names>JA</given-names></name><name><surname>Nielsen</surname><given-names>MB</given-names></name><name><surname>Sørensen</surname><given-names>CM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Super-Resolution Imaging with Ultrasound for Visualization of the Renal Microvasculature in Rats Before and After Renal Ischemia: A Pilot Study</article-title><source>Diagnostics (Basel, Switzerland)</source><volume>10</volume><elocation-id>11</elocation-id><pub-id pub-id-type="doi">10.3390/diagnostics10110862</pub-id><pub-id pub-id-type="pmid">33105888</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blinder</surname><given-names>P</given-names></name><name><surname>Tsai</surname><given-names>PS</given-names></name><name><surname>Kaufhold</surname><given-names>JP</given-names></name><name><surname>Knutsen</surname><given-names>PM</given-names></name><name><surname>Suhl</surname><given-names>H</given-names></name><name><surname>Kleinfeld</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The cortical angiome: an interconnected vascular network with noncolumnar patterns of blood flow</article-title><source>Nature Neuroscience</source><volume>16</volume><fpage>889</fpage><lpage>897</lpage><pub-id pub-id-type="doi">10.1038/nn.3426</pub-id><pub-id pub-id-type="pmid">23749145</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boer</surname><given-names>WH</given-names></name><name><surname>Braam</surname><given-names>B</given-names></name><name><surname>Fransen</surname><given-names>R</given-names></name><name><surname>Boer</surname><given-names>P</given-names></name><name><surname>Koomans</surname><given-names>HA</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Effects of reduced renal perfusion pressure and acute volume expansion on proximal tubule and whole kidney angiotensin II content in the rat</article-title><source>Kidney International</source><volume>51</volume><fpage>44</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1038/ki.1997.6</pub-id><pub-id pub-id-type="pmid">8995716</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bongoni</surname><given-names>AK</given-names></name><name><surname>Lu</surname><given-names>B</given-names></name><name><surname>McRae</surname><given-names>JL</given-names></name><name><surname>Salvaris</surname><given-names>EJ</given-names></name><name><surname>Toonen</surname><given-names>EJM</given-names></name><name><surname>Vikstrom</surname><given-names>I</given-names></name><name><surname>Baz Morelli</surname><given-names>A</given-names></name><name><surname>Pearse</surname><given-names>MJ</given-names></name><name><surname>Cowan</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Complement-mediated Damage to the Glycocalyx Plays a Role in Renal Ischemia-reperfusion Injury in Mice</article-title><source>Transplantation Direct</source><volume>5</volume><elocation-id>e341</elocation-id><pub-id pub-id-type="doi">10.1097/TXD.0000000000000881</pub-id><pub-id pub-id-type="pmid">30993186</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonventre</surname><given-names>JV</given-names></name><name><surname>Weinberg</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Recent advances in the pathophysiology of ischemic acute renal failure</article-title><source>Journal of the American Society of Nephrology</source><volume>14</volume><fpage>2199</fpage><lpage>2210</lpage><pub-id pub-id-type="doi">10.1097/01.asn.0000079785.13922.f6</pub-id><pub-id pub-id-type="pmid">12874476</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brezis</surname><given-names>M</given-names></name><name><surname>Heyman</surname><given-names>SN</given-names></name><name><surname>Dinour</surname><given-names>D</given-names></name><name><surname>Epstein</surname><given-names>FH</given-names></name><name><surname>Rosen</surname><given-names>S</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Role of nitric oxide in renal medullary oxygenation Studies in isolated and intact rat kidneys</article-title><source>The Journal of Clinical Investigation</source><volume>88</volume><fpage>390</fpage><lpage>395</lpage><pub-id pub-id-type="doi">10.1172/JCI115316</pub-id><pub-id pub-id-type="pmid">1864953</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brezis</surname><given-names>M</given-names></name><name><surname>Agmon</surname><given-names>Y</given-names></name><name><surname>Epstein</surname><given-names>FH</given-names></name></person-group><year iso-8601-date="1994">1994a</year><article-title>Determinants of intrarenal oxygenation. I. Effects of diuretics</article-title><source>The American Journal of Physiology</source><volume>267</volume><fpage>F1059</fpage><lpage>F1062</lpage><pub-id pub-id-type="doi">10.1152/ajprenal.1994.267.6.F1059</pub-id><pub-id pub-id-type="pmid">7810692</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brezis</surname><given-names>M</given-names></name><name><surname>Heyman</surname><given-names>SN</given-names></name><name><surname>Epstein</surname><given-names>FH</given-names></name></person-group><year iso-8601-date="1994">1994b</year><article-title>Determinants of intrarenal oxygenation</article-title><source>II. Hemodynamic Effects. Am J Physiol</source><volume>267</volume><fpage>F1063</fpage><lpage>F1068</lpage><pub-id pub-id-type="doi">10.1152/ajprenal.1994.267.6.F1063</pub-id><pub-id pub-id-type="pmid">7810693</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conesa</surname><given-names>EL</given-names></name><name><surname>Valero</surname><given-names>F</given-names></name><name><surname>Nadal</surname><given-names>JC</given-names></name><name><surname>Fenoy</surname><given-names>FJ</given-names></name><name><surname>López</surname><given-names>B</given-names></name><name><surname>Arregui</surname><given-names>B</given-names></name><name><surname>Salom</surname><given-names>MG</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>N-acetyl-L-cysteine improves renal medullary hypoperfusion in acute renal failure</article-title><source>American Journal of Physiology. Regulatory, Integrative and Comparative Physiology</source><volume>281</volume><fpage>R730</fpage><lpage>R737</lpage><pub-id pub-id-type="doi">10.1152/ajpregu.2001.281.3.R730</pub-id><pub-id pub-id-type="pmid">11506986</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crawford</surname><given-names>C</given-names></name><name><surname>Kennedy-Lydon</surname><given-names>T</given-names></name><name><surname>Sprott</surname><given-names>C</given-names></name><name><surname>Desai</surname><given-names>T</given-names></name><name><surname>Sawbridge</surname><given-names>L</given-names></name><name><surname>Munday</surname><given-names>J</given-names></name><name><surname>Unwin</surname><given-names>RJ</given-names></name><name><surname>Wildman</surname><given-names>SSP</given-names></name><name><surname>Peppiatt-Wildman</surname><given-names>CM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>An intact kidney slice model to investigate vasa recta properties and function in situ</article-title><source>Nephron. Physiology</source><volume>120</volume><fpage>17</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1159/000339110</pub-id><pub-id pub-id-type="pmid">22833057</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crislip</surname><given-names>GR</given-names></name><name><surname>O’Connor</surname><given-names>PM</given-names></name><name><surname>Wei</surname><given-names>Q</given-names></name><name><surname>Sullivan</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Vasa recta pericyte density is negatively associated with vascular congestion in the renal medulla following ischemia reperfusion in rats</article-title><source>American Journal of Physiology. Renal Physiology</source><volume>313</volume><fpage>F1097</fpage><lpage>F1105</lpage><pub-id pub-id-type="doi">10.1152/ajprenal.00261.2017</pub-id><pub-id pub-id-type="pmid">28794065</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cristol</surname><given-names>JP</given-names></name><name><surname>Thiemermann</surname><given-names>C</given-names></name><name><surname>Guérin</surname><given-names>MC</given-names></name><name><surname>Torreilles</surname><given-names>J</given-names></name><name><surname>de Paulet</surname><given-names>AC</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>L-Arginine infusion after ischaemia-reperfusion of rat kidney enhances lipid peroxidation</article-title><source>Journal of Lipid Mediators and Cell Signalling</source><volume>13</volume><fpage>9</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1016/0929-7855(95)00010-0</pub-id><pub-id pub-id-type="pmid">8821807</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>da Silveira</surname><given-names>KD</given-names></name><name><surname>Pompermayer Bosco</surname><given-names>KS</given-names></name><name><surname>Diniz</surname><given-names>LRL</given-names></name><name><surname>Carmona</surname><given-names>AK</given-names></name><name><surname>Cassali</surname><given-names>GD</given-names></name><name><surname>Bruna-Romero</surname><given-names>O</given-names></name><name><surname>de Sousa</surname><given-names>LP</given-names></name><name><surname>Teixeira</surname><given-names>MM</given-names></name><name><surname>Santos</surname><given-names>RAS</given-names></name><name><surname>Simões e Silva</surname><given-names>AC</given-names></name><name><surname>Ribeiro Vieira</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>ACE2-angiotensin-(1-7)-Mas axis in renal ischaemia/reperfusion injury in rats</article-title><source>Clinical Science (London, England</source><volume>119</volume><fpage>385</fpage><lpage>394</lpage><pub-id pub-id-type="doi">10.1042/CS20090554</pub-id><pub-id pub-id-type="pmid">20528771</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunn</surname><given-names>KW</given-names></name><name><surname>Sutton</surname><given-names>TA</given-names></name><name><surname>Sandoval</surname><given-names>RM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Live-Animal Imaging of Renal Function by Multiphoton Microscopy</article-title><source>Current Protocols in Cytometry</source><volume>83</volume><elocation-id>12</elocation-id><pub-id pub-id-type="doi">10.1002/cpcy.32</pub-id><pub-id pub-id-type="pmid">29345326</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durham</surname><given-names>JT</given-names></name><name><surname>Surks</surname><given-names>HK</given-names></name><name><surname>Dulmovits</surname><given-names>BM</given-names></name><name><surname>Herman</surname><given-names>IM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Pericyte contractility controls endothelial cell cycle progression and sprouting: insights into angiogenic switch mechanics</article-title><source>American Journal of Physiology. Cell Physiology</source><volume>307</volume><fpage>C878</fpage><lpage>C892</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.00185.2014</pub-id><pub-id pub-id-type="pmid">25143350</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Epstein</surname><given-names>FH</given-names></name><name><surname>Balaban</surname><given-names>RS</given-names></name><name><surname>Ross</surname><given-names>BD</given-names></name></person-group><year iso-8601-date="1982">1982</year><article-title>Redox state of cytochrome aa3 in isolated perfused rat kidney</article-title><source>The American Journal of Physiology</source><volume>243</volume><fpage>F356</fpage><lpage>F363</lpage><pub-id pub-id-type="doi">10.1152/ajprenal.1982.243.4.F356</pub-id><pub-id pub-id-type="pmid">6289677</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>RG</given-names></name><name><surname>Ince</surname><given-names>C</given-names></name><name><surname>Joles</surname><given-names>JA</given-names></name><name><surname>Smith</surname><given-names>DW</given-names></name><name><surname>May</surname><given-names>CN</given-names></name><name><surname>O’Connor</surname><given-names>PM</given-names></name><name><surname>Gardiner</surname><given-names>BS</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Haemodynamic influences on kidney oxygenation: clinical implications of integrative physiology</article-title><source>Clinical and Experimental Pharmacology &amp; Physiology</source><volume>40</volume><fpage>106</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1111/1440-1681.12031</pub-id><pub-id pub-id-type="pmid">23167537</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farkas</surname><given-names>E</given-names></name><name><surname>Luiten</surname><given-names>PGM</given-names></name><name><surname>Bari</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Permanent, bilateral common carotid artery occlusion in the rat: a model for chronic cerebral hypoperfusion-related neurodegenerative diseases</article-title><source>Brain Research Reviews</source><volume>54</volume><fpage>162</fpage><lpage>180</lpage><pub-id pub-id-type="doi">10.1016/j.brainresrev.2007.01.003</pub-id><pub-id pub-id-type="pmid">17296232</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fredriksson</surname><given-names>I</given-names></name><name><surname>Larsson</surname><given-names>M</given-names></name><name><surname>Strömberg</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Measurement depth and volume in laser Doppler flowmetry</article-title><source>Microvascular Research</source><volume>78</volume><fpage>4</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1016/j.mvr.2009.02.008</pub-id><pub-id pub-id-type="pmid">19285089</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>Y</given-names></name><name><surname>Tang</surname><given-names>C</given-names></name><name><surname>Cai</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>G</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name><name><surname>Dong</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Rodent models of AKI-CKD transition</article-title><source>American Journal of Physiology. Renal Physiology</source><volume>315</volume><fpage>F1098</fpage><lpage>F1106</lpage><pub-id pub-id-type="doi">10.1152/ajprenal.00199.2018</pub-id><pub-id pub-id-type="pmid">29949392</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gameiro</surname><given-names>J</given-names></name><name><surname>Agapito Fonseca</surname><given-names>J</given-names></name><name><surname>Jorge</surname><given-names>S</given-names></name><name><surname>Lopes</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Acute Kidney Injury Definition and Diagnosis: A</article-title><source>Journal of Clinical Medicine</source><volume>7</volume><elocation-id>307</elocation-id><pub-id pub-id-type="doi">10.3390/jcm7100307</pub-id><pub-id pub-id-type="pmid">30274164</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gandolfo</surname><given-names>MT</given-names></name><name><surname>Jang</surname><given-names>HR</given-names></name><name><surname>Bagnasco</surname><given-names>SM</given-names></name><name><surname>Ko</surname><given-names>G-J</given-names></name><name><surname>Agreda</surname><given-names>P</given-names></name><name><surname>Satpute</surname><given-names>SR</given-names></name><name><surname>Crow</surname><given-names>MT</given-names></name><name><surname>King</surname><given-names>LS</given-names></name><name><surname>Rabb</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Foxp3+ regulatory T cells participate in repair of ischemic acute kidney injury</article-title><source>Kidney International</source><volume>76</volume><fpage>717</fpage><lpage>729</lpage><pub-id pub-id-type="doi">10.1038/ki.2009.259</pub-id><pub-id pub-id-type="pmid">19625990</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaudin</surname><given-names>A</given-names></name><name><surname>Yemisci</surname><given-names>M</given-names></name><name><surname>Eroglu</surname><given-names>H</given-names></name><name><surname>Lepetre-Mouelhi</surname><given-names>S</given-names></name><name><surname>Turkoglu</surname><given-names>OF</given-names></name><name><surname>Dönmez-Demir</surname><given-names>B</given-names></name><name><surname>Caban</surname><given-names>S</given-names></name><name><surname>Sargon</surname><given-names>MF</given-names></name><name><surname>Garcia-Argote</surname><given-names>S</given-names></name><name><surname>Pieters</surname><given-names>G</given-names></name><name><surname>Loreau</surname><given-names>O</given-names></name><name><surname>Rousseau</surname><given-names>B</given-names></name><name><surname>Tagit</surname><given-names>O</given-names></name><name><surname>Hildebrandt</surname><given-names>N</given-names></name><name><surname>Le Dantec</surname><given-names>Y</given-names></name><name><surname>Mougin</surname><given-names>J</given-names></name><name><surname>Valetti</surname><given-names>S</given-names></name><name><surname>Chacun</surname><given-names>H</given-names></name><name><surname>Nicolas</surname><given-names>V</given-names></name><name><surname>Desmaële</surname><given-names>D</given-names></name><name><surname>Andrieux</surname><given-names>K</given-names></name><name><surname>Capan</surname><given-names>Y</given-names></name><name><surname>Dalkara</surname><given-names>T</given-names></name><name><surname>Couvreur</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Squalenoyl adenosine nanoparticles provide neuroprotection after stroke and spinal cord injury</article-title><source>Nature Nanotechnology</source><volume>9</volume><fpage>1054</fpage><lpage>1062</lpage><pub-id pub-id-type="doi">10.1038/nnano.2014.274</pub-id><pub-id pub-id-type="pmid">25420034</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>CN</given-names></name><name><surname>Reynell</surname><given-names>C</given-names></name><name><surname>Gesslein</surname><given-names>B</given-names></name><name><surname>Hamilton</surname><given-names>NB</given-names></name><name><surname>Mishra</surname><given-names>A</given-names></name><name><surname>Sutherland</surname><given-names>BA</given-names></name><name><surname>O’Farrell</surname><given-names>FM</given-names></name><name><surname>Buchan</surname><given-names>AM</given-names></name><name><surname>Lauritzen</surname><given-names>M</given-names></name><name><surname>Attwell</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Capillary pericytes regulate cerebral blood flow in health and disease</article-title><source>Nature</source><volume>508</volume><fpage>55</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1038/nature13165</pub-id><pub-id pub-id-type="pmid">24670647</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartmann</surname><given-names>DA</given-names></name><name><surname>Berthiaume</surname><given-names>A-A</given-names></name><name><surname>Grant</surname><given-names>RI</given-names></name><name><surname>Harrill</surname><given-names>SA</given-names></name><name><surname>Koski</surname><given-names>T</given-names></name><name><surname>Tieu</surname><given-names>T</given-names></name><name><surname>McDowell</surname><given-names>KP</given-names></name><name><surname>Faino</surname><given-names>AV</given-names></name><name><surname>Kelly</surname><given-names>AL</given-names></name><name><surname>Shih</surname><given-names>AY</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Brain capillary pericytes exert a substantial but slow influence on blood flow</article-title><source>Nature Neuroscience</source><volume>24</volume><fpage>633</fpage><lpage>645</lpage><pub-id pub-id-type="doi">10.1038/s41593-020-00793-2</pub-id><pub-id pub-id-type="pmid">33603231</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirunpattarasilp</surname><given-names>C</given-names></name><name><surname>Attwell</surname><given-names>D</given-names></name><name><surname>Freitas</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The role of pericytes in brain disorders: from the periphery to the brain</article-title><source>Journal of Neurochemistry</source><volume>150</volume><fpage>648</fpage><lpage>665</lpage><pub-id pub-id-type="doi">10.1111/jnc.14725</pub-id><pub-id pub-id-type="pmid">31106417</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hollenbeck</surname><given-names>BK</given-names></name><name><surname>Taub</surname><given-names>DA</given-names></name><name><surname>Miller</surname><given-names>DC</given-names></name><name><surname>Dunn</surname><given-names>RL</given-names></name><name><surname>Wei</surname><given-names>JT</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>National utilization trends of partial nephrectomy for renal cell carcinoma: a case of underutilization</article-title><source>Urology</source><volume>67</volume><fpage>254</fpage><lpage>259</lpage><pub-id pub-id-type="doi">10.1016/j.urology.2005.08.050</pub-id><pub-id pub-id-type="pmid">16442601</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Homma</surname><given-names>K</given-names></name><name><surname>Hayashi</surname><given-names>K</given-names></name><name><surname>Wakino</surname><given-names>S</given-names></name><name><surname>Tokuyama</surname><given-names>H</given-names></name><name><surname>Kanda</surname><given-names>T</given-names></name><name><surname>Tatematsu</surname><given-names>S</given-names></name><name><surname>Hasegawa</surname><given-names>K</given-names></name><name><surname>Fujishima</surname><given-names>S</given-names></name><name><surname>Hori</surname><given-names>S</given-names></name><name><surname>Saruta</surname><given-names>T</given-names></name><name><surname>Itoh</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Rho-kinase contributes to pressure-induced constriction of renal microvessels</article-title><source>The Keio Journal of Medicine</source><volume>63</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.2302/kjm.2013-0001-oa</pub-id><pub-id pub-id-type="pmid">24429483</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoste</surname><given-names>EAJ</given-names></name><name><surname>Kellum</surname><given-names>JA</given-names></name><name><surname>Selby</surname><given-names>NM</given-names></name><name><surname>Zarbock</surname><given-names>A</given-names></name><name><surname>Palevsky</surname><given-names>PM</given-names></name><name><surname>Bagshaw</surname><given-names>SM</given-names></name><name><surname>Goldstein</surname><given-names>SL</given-names></name><name><surname>Cerdá</surname><given-names>J</given-names></name><name><surname>Chawla</surname><given-names>LS</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Global epidemiology and outcomes of acute kidney injury</article-title><source>Nature Reviews. Nephrology</source><volume>14</volume><fpage>607</fpage><lpage>625</lpage><pub-id pub-id-type="doi">10.1038/s41581-018-0052-0</pub-id><pub-id pub-id-type="pmid">30135570</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ichimura</surname><given-names>T</given-names></name><name><surname>Bonventre</surname><given-names>JV</given-names></name><name><surname>Bailly</surname><given-names>V</given-names></name><name><surname>Wei</surname><given-names>H</given-names></name><name><surname>Hession</surname><given-names>CA</given-names></name><name><surname>Cate</surname><given-names>RL</given-names></name><name><surname>Sanicola</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury</article-title><source>The Journal of Biological Chemistry</source><volume>273</volume><fpage>4135</fpage><lpage>4142</lpage><pub-id pub-id-type="doi">10.1074/jbc.273.7.4135</pub-id><pub-id pub-id-type="pmid">9461608</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jahani</surname><given-names>V</given-names></name><name><surname>Kavousi</surname><given-names>A</given-names></name><name><surname>Mehri</surname><given-names>S</given-names></name><name><surname>Karimi</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Rho kinase, a potential target in the treatment of metabolic syndrome</article-title><source>Biomedicine &amp; Pharmacotherapy = Biomedecine &amp; Pharmacotherapie</source><volume>106</volume><fpage>1024</fpage><lpage>1030</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2018.07.060</pub-id><pub-id pub-id-type="pmid">30119167</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>NK</given-names></name><name><surname>Stewart</surname><given-names>K</given-names></name><name><surname>Czopek</surname><given-names>A</given-names></name><name><surname>Menzies</surname><given-names>RI</given-names></name><name><surname>Thomson</surname><given-names>A</given-names></name><name><surname>Moran</surname><given-names>CM</given-names></name><name><surname>Cairns</surname><given-names>C</given-names></name><name><surname>Conway</surname><given-names>BR</given-names></name><name><surname>Denby</surname><given-names>L</given-names></name><name><surname>Livingstone</surname><given-names>DEW</given-names></name><name><surname>Wiseman</surname><given-names>J</given-names></name><name><surname>Hadoke</surname><given-names>PW</given-names></name><name><surname>Webb</surname><given-names>DJ</given-names></name><name><surname>Dhaun</surname><given-names>N</given-names></name><name><surname>Dear</surname><given-names>JW</given-names></name><name><surname>Mullins</surname><given-names>JJ</given-names></name><name><surname>Bailey</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Endothelin-1 Mediates the Systemic and Renal Hemodynamic Effects of GPR81 Activation</article-title><source>Hypertension (Dallas, Tex</source><volume>75</volume><fpage>1213</fpage><lpage>1222</lpage><pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.119.14308</pub-id><pub-id pub-id-type="pmid">32200679</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname><given-names>KJ</given-names></name><name><surname>Williams</surname><given-names>WW</given-names></name><name><surname>Colvin</surname><given-names>RB</given-names></name><name><surname>Bonventre</surname><given-names>JV</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury</article-title><source>PNAS</source><volume>91</volume><fpage>812</fpage><lpage>816</lpage><pub-id pub-id-type="doi">10.1073/pnas.91.2.812</pub-id><pub-id pub-id-type="pmid">7904759</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kentrup</surname><given-names>D</given-names></name><name><surname>Reuter</surname><given-names>S</given-names></name><name><surname>Schnöckel</surname><given-names>U</given-names></name><name><surname>Grabner</surname><given-names>A</given-names></name><name><surname>Edemir</surname><given-names>B</given-names></name><name><surname>Pavenstädt</surname><given-names>H</given-names></name><name><surname>Schober</surname><given-names>O</given-names></name><name><surname>Schäfers</surname><given-names>M</given-names></name><name><surname>Schlatter</surname><given-names>E</given-names></name><name><surname>Büssemaker</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Hydroxyfasudil-mediated inhibition of ROCK1 and ROCK2 improves kidney function in rat renal acute ischemia-reperfusion injury</article-title><source>PLOS ONE</source><volume>6</volume><elocation-id>e26419</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0026419</pub-id><pub-id pub-id-type="pmid">22031832</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khairoun</surname><given-names>M</given-names></name><name><surname>van der Pol</surname><given-names>P</given-names></name><name><surname>de Vries</surname><given-names>DK</given-names></name><name><surname>Lievers</surname><given-names>E</given-names></name><name><surname>Schlagwein</surname><given-names>N</given-names></name><name><surname>de Boer</surname><given-names>HC</given-names></name><name><surname>Bajema</surname><given-names>IM</given-names></name><name><surname>Rotmans</surname><given-names>JI</given-names></name><name><surname>van Zonneveld</surname><given-names>AJ</given-names></name><name><surname>Rabelink</surname><given-names>TJ</given-names></name><name><surname>van Kooten</surname><given-names>C</given-names></name><name><surname>Reinders</surname><given-names>MEJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Renal ischemia-reperfusion induces a dysbalance of angiopoietins, accompanied by proliferation of pericytes and fibrosis</article-title><source>American Journal of Physiology. Renal Physiology</source><volume>305</volume><fpage>F901</fpage><lpage>F910</lpage><pub-id pub-id-type="doi">10.1152/ajprenal.00542.2012</pub-id><pub-id pub-id-type="pmid">23825073</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimura</surname><given-names>K</given-names></name><name><surname>Ito</surname><given-names>M</given-names></name><name><surname>Amano</surname><given-names>M</given-names></name><name><surname>Chihara</surname><given-names>K</given-names></name><name><surname>Fukata</surname><given-names>Y</given-names></name><name><surname>Nakafuku</surname><given-names>M</given-names></name><name><surname>Yamamori</surname><given-names>B</given-names></name><name><surname>Feng</surname><given-names>J</given-names></name><name><surname>Nakano</surname><given-names>T</given-names></name><name><surname>Okawa</surname><given-names>K</given-names></name><name><surname>Iwamatsu</surname><given-names>A</given-names></name><name><surname>Kaibuchi</surname><given-names>K</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase)</article-title><source>Science (New York, N.Y.)</source><volume>273</volume><fpage>245</fpage><lpage>248</lpage><pub-id pub-id-type="doi">10.1126/science.273.5272.245</pub-id><pub-id pub-id-type="pmid">8662509</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kramann</surname><given-names>R</given-names></name><name><surname>Wongboonsin</surname><given-names>J</given-names></name><name><surname>Chang-Panesso</surname><given-names>M</given-names></name><name><surname>Machado</surname><given-names>FG</given-names></name><name><surname>Humphreys</surname><given-names>BD</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Gli1(+) Pericyte Loss Induces Capillary Rarefaction and Proximal Tubular Injury</article-title><source>Journal of the American Society of Nephrology</source><volume>28</volume><fpage>776</fpage><lpage>784</lpage><pub-id pub-id-type="doi">10.1681/ASN.2016030297</pub-id><pub-id pub-id-type="pmid">27624490</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kureli</surname><given-names>G</given-names></name><name><surname>Yilmaz-Ozcan</surname><given-names>S</given-names></name><name><surname>Erdener</surname><given-names>SE</given-names></name><name><surname>Donmez-Demir</surname><given-names>B</given-names></name><name><surname>Yemisci</surname><given-names>M</given-names></name><name><surname>Karatas</surname><given-names>H</given-names></name><name><surname>Dalkara</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>F-actin polymerization contributes to pericyte contractility in retinal capillaries</article-title><source>Experimental Neurology</source><volume>332</volume><elocation-id>113392</elocation-id><pub-id pub-id-type="doi">10.1016/j.expneurol.2020.113392</pub-id><pub-id pub-id-type="pmid">32610106</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kushiyama</surname><given-names>T</given-names></name><name><surname>Oda</surname><given-names>T</given-names></name><name><surname>Yamamoto</surname><given-names>K</given-names></name><name><surname>Higashi</surname><given-names>K</given-names></name><name><surname>Watanabe</surname><given-names>A</given-names></name><name><surname>Takechi</surname><given-names>H</given-names></name><name><surname>Uchida</surname><given-names>T</given-names></name><name><surname>Oshima</surname><given-names>N</given-names></name><name><surname>Sakurai</surname><given-names>Y</given-names></name><name><surname>Miura</surname><given-names>S</given-names></name><name><surname>Kumagai</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Protective effects of Rho kinase inhibitor fasudil on rats with chronic kidney disease</article-title><source>American Journal of Physiology. Renal Physiology</source><volume>304</volume><fpage>F1325</fpage><lpage>F1334</lpage><pub-id pub-id-type="doi">10.1152/ajprenal.00447.2012</pub-id><pub-id pub-id-type="pmid">23552860</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kutcher</surname><given-names>ME</given-names></name><name><surname>Kolyada</surname><given-names>AY</given-names></name><name><surname>Surks</surname><given-names>HK</given-names></name><name><surname>Herman</surname><given-names>IM</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Pericyte Rho GTPase mediates both pericyte contractile phenotype and capillary endothelial growth state</article-title><source>The American Journal of Pathology</source><volume>171</volume><fpage>693</fpage><lpage>701</lpage><pub-id pub-id-type="doi">10.2353/ajpath.2007.070102</pub-id><pub-id pub-id-type="pmid">17556591</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kutcher</surname><given-names>ME</given-names></name><name><surname>Herman</surname><given-names>IM</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The pericyte: cellular regulator of microvascular blood flow</article-title><source>Microvascular Research</source><volume>77</volume><fpage>235</fpage><lpage>246</lpage><pub-id pub-id-type="doi">10.1016/j.mvr.2009.01.007</pub-id><pub-id pub-id-type="pmid">19323975</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kutuzov</surname><given-names>N</given-names></name><name><surname>Flyvbjerg</surname><given-names>H</given-names></name><name><surname>Lauritzen</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Contributions of the glycocalyx, endothelium, and extravascular compartment to the blood-brain barrier</article-title><source>PNAS</source><volume>115</volume><fpage>E9429</fpage><lpage>E9438</lpage><pub-id pub-id-type="doi">10.1073/pnas.1802155115</pub-id><pub-id pub-id-type="pmid">30217895</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname><given-names>O</given-names></name><name><surname>Hong</surname><given-names>SM</given-names></name><name><surname>Sutton</surname><given-names>TA</given-names></name><name><surname>Temm</surname><given-names>CJ</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Preservation of peritubular capillary endothelial integrity and increasing pericytes may be critical to recovery from postischemic acute kidney injury</article-title><source>American Journal of Physiology-Renal Physiology</source><volume>295</volume><fpage>F351</fpage><lpage>F359</lpage><pub-id pub-id-type="doi">10.1152/ajprenal.90276.2008</pub-id><pub-id pub-id-type="pmid">18562634</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lameire</surname><given-names>N</given-names></name><name><surname>Vanholder</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Pathophysiologic features and prevention of human and experimental acute tubular necrosis</article-title><source>Journal of the American Society of Nephrology</source><volume>12 Suppl 17</volume><fpage>S20</fpage><lpage>S32</lpage><pub-id pub-id-type="pmid">11251028</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lameire</surname><given-names>N</given-names></name><name><surname>Van Biesen</surname><given-names>W</given-names></name><name><surname>Vanholder</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The changing epidemiology of acute renal failure</article-title><source>Nature Clinical Practice Nephrology</source><volume>2</volume><fpage>364</fpage><lpage>377</lpage><pub-id pub-id-type="doi">10.1038/ncpneph0218</pub-id><pub-id pub-id-type="pmid">16932465</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le Clef</surname><given-names>N</given-names></name><name><surname>Verhulst</surname><given-names>A</given-names></name><name><surname>D’Haese</surname><given-names>PC</given-names></name><name><surname>Vervaet</surname><given-names>BA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Unilateral Renal Ischemia-Reperfusion as a Robust Model for Acute to Chronic Kidney Injury in Mice</article-title><source>PLOS ONE</source><volume>11</volume><elocation-id>e0152153</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0152153</pub-id><pub-id pub-id-type="pmid">27007127</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>TM</given-names></name><name><surname>Chung</surname><given-names>TH</given-names></name><name><surname>Lin</surname><given-names>SZ</given-names></name><name><surname>Chang</surname><given-names>NC</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Endothelin receptor blockade ameliorates renal injury by inhibition of RhoA/Rho-kinase signalling in deoxycorticosterone acetate-salt hypertensive rats</article-title><source>Journal of Hypertension</source><volume>32</volume><fpage>795</fpage><lpage>805</lpage><pub-id pub-id-type="doi">10.1097/HJH.0000000000000092</pub-id><pub-id pub-id-type="pmid">24463935</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leonhardt</surname><given-names>KO</given-names></name><name><surname>Landes</surname><given-names>RR</given-names></name></person-group><year iso-8601-date="1963">1963</year><article-title>Oxygen tension of the urine and renal structures</article-title><source>New England Journal of Medicine</source><volume>269</volume><fpage>115</fpage><lpage>121</lpage><pub-id pub-id-type="doi">10.1056/NEJM196307182690301</pub-id><pub-id pub-id-type="pmid">13929733</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lima-Posada</surname><given-names>I</given-names></name><name><surname>Portas-Cortés</surname><given-names>C</given-names></name><name><surname>Pérez-Villalva</surname><given-names>R</given-names></name><name><surname>Fontana</surname><given-names>F</given-names></name><name><surname>Rodríguez-Romo</surname><given-names>R</given-names></name><name><surname>Prieto</surname><given-names>R</given-names></name><name><surname>Sánchez-Navarro</surname><given-names>A</given-names></name><name><surname>Rodríguez-González</surname><given-names>GL</given-names></name><name><surname>Gamba</surname><given-names>G</given-names></name><name><surname>Zambrano</surname><given-names>E</given-names></name><name><surname>Bobadilla</surname><given-names>NA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Gender Differences in the Acute Kidney Injury to Chronic Kidney Disease Transition</article-title><source>Scientific Reports</source><volume>7</volume><elocation-id>12270</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-017-09630-2</pub-id><pub-id pub-id-type="pmid">28947737</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lingor</surname><given-names>P</given-names></name><name><surname>Weber</surname><given-names>M</given-names></name><name><surname>Camu</surname><given-names>W</given-names></name><name><surname>Friede</surname><given-names>T</given-names></name><name><surname>Hilgers</surname><given-names>R</given-names></name><name><surname>Leha</surname><given-names>A</given-names></name><name><surname>Neuwirth</surname><given-names>C</given-names></name><name><surname>Günther</surname><given-names>R</given-names></name><name><surname>Benatar</surname><given-names>M</given-names></name><name><surname>Kuzma-Kozakiewicz</surname><given-names>M</given-names></name><name><surname>Bidner</surname><given-names>H</given-names></name><name><surname>Blankenstein</surname><given-names>C</given-names></name><name><surname>Frontini</surname><given-names>R</given-names></name><name><surname>Ludolph</surname><given-names>A</given-names></name><name><surname>Koch</surname><given-names>JC</given-names></name><collab>ROCK-ALS Investigators</collab></person-group><year iso-8601-date="2019">2019</year><article-title>ROCK-ALS: Protocol for a Randomized, Placebo-Controlled, Double-Blind Phase IIa Trial of Safety, Tolerability and Efficacy of the Rho Kinase (ROCK) Inhibitor Fasudil in Amyotrophic Lateral Sclerosis</article-title><source>Frontiers in Neurology</source><volume>10</volume><elocation-id>293</elocation-id><pub-id pub-id-type="doi">10.3389/fneur.2019.00293</pub-id><pub-id pub-id-type="pmid">30972018</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Dong</surname><given-names>H</given-names></name><name><surname>Huang</surname><given-names>B</given-names></name><name><surname>Miao</surname><given-names>H</given-names></name><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Yuan</surname><given-names>Y</given-names></name><name><surname>Qiu</surname><given-names>F</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Quan</surname><given-names>X</given-names></name><name><surname>Zhu</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Native Coronary Collateral Microcirculation Reserve in Rat Hearts</article-title><source>Journal of the American Heart Association</source><volume>8</volume><elocation-id>e011220</elocation-id><pub-id pub-id-type="doi">10.1161/JAHA.118.011220</pub-id><pub-id pub-id-type="pmid">30819021</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>S</given-names></name><name><surname>Mattson</surname><given-names>DL</given-names></name><name><surname>Roman</surname><given-names>RJ</given-names></name><name><surname>Becker</surname><given-names>CG</given-names></name><name><surname>Cowley</surname><given-names>AW</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Assessment of changes in intrarenal blood flow in conscious rats using laser-Doppler flowmetry</article-title><source>American Journal of Physiology-Renal Physiology</source><volume>264</volume><fpage>F956</fpage><lpage>F962</lpage><pub-id pub-id-type="doi">10.1152/ajprenal.1993.264.6.F956</pub-id><pub-id pub-id-type="pmid">8322898</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maeda</surname><given-names>Y</given-names></name><name><surname>Hirano</surname><given-names>K</given-names></name><name><surname>Nishimura</surname><given-names>J</given-names></name><name><surname>Sasaki</surname><given-names>T</given-names></name><name><surname>Kanaide</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Rho-kinase inhibitor inhibits both myosin phosphorylation-dependent and -independent enhancement of myofilament Ca2+ sensitivity in the bovine middle cerebral artery</article-title><source>British Journal of Pharmacology</source><volume>140</volume><fpage>871</fpage><lpage>880</lpage><pub-id pub-id-type="doi">10.1038/sj.bjp.0705487</pub-id><pub-id pub-id-type="pmid">14530221</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maekawa</surname><given-names>M</given-names></name><name><surname>Ishizaki</surname><given-names>T</given-names></name><name><surname>Boku</surname><given-names>S</given-names></name><name><surname>Watanabe</surname><given-names>N</given-names></name><name><surname>Fujita</surname><given-names>A</given-names></name><name><surname>Iwamatsu</surname><given-names>A</given-names></name><name><surname>Obinata</surname><given-names>T</given-names></name><name><surname>Ohashi</surname><given-names>K</given-names></name><name><surname>Mizuno</surname><given-names>K</given-names></name><name><surname>Narumiya</surname><given-names>S</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase</article-title><source>Science</source><volume>285</volume><fpage>895</fpage><lpage>898</lpage><pub-id pub-id-type="doi">10.1126/science.285.5429.895</pub-id><pub-id pub-id-type="pmid">10436159</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCurley</surname><given-names>A</given-names></name><name><surname>Alimperti</surname><given-names>S</given-names></name><name><surname>Campos-Bilderback</surname><given-names>SB</given-names></name><name><surname>Sandoval</surname><given-names>RM</given-names></name><name><surname>Calvino</surname><given-names>JE</given-names></name><name><surname>Reynolds</surname><given-names>TL</given-names></name><name><surname>Crackower</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Inhibition of alphavbeta5 Integrin Attenuates Vascular Permeability and Protects against Renal Ischemia-Reperfusion Injury</article-title><source>Journal of the American Society of Nephrology: JASN</source><volume>28</volume><fpage>1741</fpage><lpage>1752</lpage><pub-id pub-id-type="doi">10.1681/ASN.2016020200</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medina-Rico</surname><given-names>M</given-names></name><name><surname>López-Ramos</surname><given-names>H</given-names></name><name><surname>Lobo</surname><given-names>M</given-names></name><name><surname>Romo</surname><given-names>J</given-names></name><name><surname>Guillermo Prada</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Epidemiology of renal cancer in developing countries: Review of the literature</article-title><source>Canadian Urological Association Journal</source><volume>12</volume><fpage>E154</fpage><lpage>E162</lpage><pub-id pub-id-type="doi">10.5489/cuaj.4464</pub-id><pub-id pub-id-type="pmid">29283089</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehta</surname><given-names>RL</given-names></name><name><surname>Burdmann</surname><given-names>EA</given-names></name><name><surname>Cerdá</surname><given-names>J</given-names></name><name><surname>Feehally</surname><given-names>J</given-names></name><name><surname>Finkelstein</surname><given-names>F</given-names></name><name><surname>García-García</surname><given-names>G</given-names></name><name><surname>Godin</surname><given-names>M</given-names></name><name><surname>Jha</surname><given-names>V</given-names></name><name><surname>Lameire</surname><given-names>NH</given-names></name><name><surname>Levin</surname><given-names>NW</given-names></name><name><surname>Lewington</surname><given-names>A</given-names></name><name><surname>Lombardi</surname><given-names>R</given-names></name><name><surname>Macedo</surname><given-names>E</given-names></name><name><surname>Rocco</surname><given-names>M</given-names></name><name><surname>Aronoff-Spencer</surname><given-names>E</given-names></name><name><surname>Tonelli</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Remuzzi</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Recognition and management of acute kidney injury in the International Society of Nephrology 0by25 Global Snapshot: a multinational cross-sectional study</article-title><source>The Lancet</source><volume>387</volume><fpage>2017</fpage><lpage>2025</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(16)30240-9</pub-id><pub-id pub-id-type="pmid">27086173</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minhas</surname><given-names>G</given-names></name><name><surname>Morishita</surname><given-names>R</given-names></name><name><surname>Anand</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Preclinical models to investigate retinal ischemia: advances and drawbacks</article-title><source>Frontiers in Neurology</source><volume>3</volume><elocation-id>75</elocation-id><pub-id pub-id-type="doi">10.3389/fneur.2012.00075</pub-id><pub-id pub-id-type="pmid">22593752</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Missbach-Guentner</surname><given-names>J</given-names></name><name><surname>Pinkert-Leetsch</surname><given-names>D</given-names></name><name><surname>Dullin</surname><given-names>C</given-names></name><name><surname>Ufartes</surname><given-names>R</given-names></name><name><surname>Hornung</surname><given-names>D</given-names></name><name><surname>Tampe</surname><given-names>B</given-names></name><name><surname>Zeisberg</surname><given-names>M</given-names></name><name><surname>Alves</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>3D virtual histology of murine kidneys -high resolution visualization of pathological alterations by micro computed tomography</article-title><source>Scientific Reports</source><volume>8</volume><elocation-id>1407</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-018-19773-5</pub-id><pub-id pub-id-type="pmid">29362427</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyata</surname><given-names>N</given-names></name><name><surname>Park</surname><given-names>F</given-names></name><name><surname>Li</surname><given-names>XF</given-names></name><name><surname>Cowley</surname><given-names>AW</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Distribution of angiotensin AT1 and AT2 receptor subtypes in the rat kidney</article-title><source>The American Journal of Physiology</source><volume>277</volume><fpage>F437</fpage><lpage>F446</lpage><pub-id pub-id-type="doi">10.1152/ajprenal.1999.277.3.F437</pub-id><pub-id pub-id-type="pmid">10484527</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Müller</surname><given-names>V</given-names></name><name><surname>Losonczy</surname><given-names>G</given-names></name><name><surname>Heemann</surname><given-names>U</given-names></name><name><surname>Vannay</surname><given-names>A</given-names></name><name><surname>Fekete</surname><given-names>A</given-names></name><name><surname>Reusz</surname><given-names>G</given-names></name><name><surname>Tulassay</surname><given-names>T</given-names></name><name><surname>Szabó</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Sexual dimorphism in renal ischemia-reperfusion injury in rats: possible role of endothelin</article-title><source>Kidney International</source><volume>62</volume><fpage>1364</fpage><lpage>1371</lpage><pub-id pub-id-type="doi">10.1111/j.1523-1755.2002.kid590.x</pub-id><pub-id pub-id-type="pmid">12234307</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nijveldt</surname><given-names>RJ</given-names></name><name><surname>Prins</surname><given-names>HA</given-names></name><name><surname>van Kemenade</surname><given-names>FJ</given-names></name><name><surname>Teerlink</surname><given-names>T</given-names></name><name><surname>van Lambalgen</surname><given-names>AA</given-names></name><name><surname>Boelens</surname><given-names>PG</given-names></name><name><surname>Rauwerda</surname><given-names>JA</given-names></name><name><surname>van Leeuwen</surname><given-names>PA</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Low arginine plasma levels do not aggravate renal blood flow after experimental renal ischaemia/reperfusion</article-title><source>European Journal of Vascular and Endovascular Surgery</source><volume>22</volume><fpage>232</fpage><lpage>239</lpage><pub-id pub-id-type="doi">10.1053/ejvs.2001.1444</pub-id><pub-id pub-id-type="pmid">11506516</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nogueira</surname><given-names>A</given-names></name><name><surname>Rocha</surname><given-names>AF</given-names></name><name><surname>Ginja</surname><given-names>M</given-names></name><name><surname>Oliveira</surname><given-names>PA</given-names></name><name><surname>Pires</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Ultrasonographic Evaluation of the Kidney in 5/6 Nephrectomized Rats: Correlation with Biochemical and Histopathological Findings</article-title><source>In Vivo</source><volume>30</volume><fpage>829</fpage><lpage>834</lpage><pub-id pub-id-type="doi">10.21873/invivo.11001</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nortley</surname><given-names>R</given-names></name><name><surname>Korte</surname><given-names>N</given-names></name><name><surname>Izquierdo</surname><given-names>P</given-names></name><name><surname>Hirunpattarasilp</surname><given-names>C</given-names></name><name><surname>Mishra</surname><given-names>A</given-names></name><name><surname>Jaunmuktane</surname><given-names>Z</given-names></name><name><surname>Kyrargyri</surname><given-names>V</given-names></name><name><surname>Pfeiffer</surname><given-names>T</given-names></name><name><surname>Khennouf</surname><given-names>L</given-names></name><name><surname>Madry</surname><given-names>C</given-names></name><name><surname>Gong</surname><given-names>H</given-names></name><name><surname>Richard-Loendt</surname><given-names>A</given-names></name><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Saito</surname><given-names>T</given-names></name><name><surname>Saido</surname><given-names>TC</given-names></name><name><surname>Brandner</surname><given-names>S</given-names></name><name><surname>Sethi</surname><given-names>H</given-names></name><name><surname>Attwell</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Amyloid beta oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes</article-title><source>Science (New York, N.Y.)</source><volume>365</volume><elocation-id>6450</elocation-id><pub-id pub-id-type="doi">10.1126/science.aav9518</pub-id><pub-id pub-id-type="pmid">31221773</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olof</surname><given-names>P</given-names></name><name><surname>Hellberg</surname><given-names>A</given-names></name><name><surname>Källskog</surname><given-names>O</given-names></name><name><surname>Wolgast</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Red cell trapping and postischemic renal blood flow Differences between the cortex, outer and inner medulla</article-title><source>Kidney International</source><volume>40</volume><fpage>625</fpage><lpage>631</lpage><pub-id pub-id-type="doi">10.1038/ki.1991.254</pub-id><pub-id pub-id-type="pmid">1745011</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Farrell</surname><given-names>FM</given-names></name><name><surname>Mastitskaya</surname><given-names>S</given-names></name><name><surname>Hammond-Haley</surname><given-names>M</given-names></name><name><surname>Freitas</surname><given-names>F</given-names></name><name><surname>Wah</surname><given-names>WR</given-names></name><name><surname>Attwell</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Capillary pericytes mediate coronary no-reflow after myocardial ischaemia</article-title><source>eLife</source><volume>6</volume><elocation-id>e29280</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.29280</pub-id><pub-id pub-id-type="pmid">29120327</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pallone</surname><given-names>TL</given-names></name><name><surname>Silldorff</surname><given-names>EP</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Pericyte regulation of renal medullary blood flow</article-title><source>Experimental Nephrology</source><volume>9</volume><fpage>165</fpage><lpage>170</lpage><pub-id pub-id-type="doi">10.1159/000052608</pub-id><pub-id pub-id-type="pmid">11340300</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pallone</surname><given-names>TL</given-names></name><name><surname>Edwards</surname><given-names>A</given-names></name><name><surname>Mattson</surname><given-names>DL</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Renal medullary circulation</article-title><source>Comprehensive Physiology</source><volume>2</volume><fpage>97</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1002/cphy.c100036</pub-id><pub-id pub-id-type="pmid">23728972</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>F</given-names></name><name><surname>Mattson</surname><given-names>DL</given-names></name><name><surname>Roberts</surname><given-names>LA</given-names></name><name><surname>Cowley</surname><given-names>AW</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Evidence for the presence of smooth muscle alpha-actin within pericytes of the renal medulla</article-title><source>American Journal of Physiology-Regulatory, Integrative and Comparative Physiology</source><volume>273</volume><fpage>R1742</fpage><lpage>R1748</lpage><pub-id pub-id-type="doi">10.1152/ajpregu.1997.273.5.R1742</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pearson</surname><given-names>JT</given-names></name><name><surname>Jenkins</surname><given-names>MJ</given-names></name><name><surname>Edgley</surname><given-names>AJ</given-names></name><name><surname>Sonobe</surname><given-names>T</given-names></name><name><surname>Joshi</surname><given-names>M</given-names></name><name><surname>Waddingham</surname><given-names>MT</given-names></name><name><surname>Fujii</surname><given-names>Y</given-names></name><name><surname>Schwenke</surname><given-names>DO</given-names></name><name><surname>Tsuchimochi</surname><given-names>H</given-names></name><name><surname>Yoshimoto</surname><given-names>M</given-names></name><name><surname>Umetani</surname><given-names>K</given-names></name><name><surname>Kelly</surname><given-names>DJ</given-names></name><name><surname>Shirai</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Acute Rho-kinase inhibition improves coronary dysfunction in vivo, in the early diabetic microcirculation</article-title><source>Cardiovascular Diabetology</source><volume>12</volume><elocation-id>111</elocation-id><pub-id pub-id-type="doi">10.1186/1475-2840-12-111</pub-id><pub-id pub-id-type="pmid">24059472</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>F</given-names></name><name><surname>Wu</surname><given-names>D</given-names></name><name><surname>Gao</surname><given-names>B</given-names></name><name><surname>Ingram</surname><given-names>AJ</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Chorneyko</surname><given-names>K</given-names></name><name><surname>McKenzie</surname><given-names>R</given-names></name><name><surname>Krepinsky</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>RhoA/Rho-kinase contribute to the pathogenesis of diabetic renal disease</article-title><source>Diabetes</source><volume>57</volume><fpage>1683</fpage><lpage>1692</lpage><pub-id pub-id-type="doi">10.2337/db07-1149</pub-id><pub-id pub-id-type="pmid">18356410</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polichnowski</surname><given-names>AJ</given-names></name><name><surname>Griffin</surname><given-names>KA</given-names></name><name><surname>Licea-Vargas</surname><given-names>H</given-names></name><name><surname>Lan</surname><given-names>R</given-names></name><name><surname>Picken</surname><given-names>MM</given-names></name><name><surname>Long</surname><given-names>J</given-names></name><name><surname>Williamson</surname><given-names>GA</given-names></name><name><surname>Rosenberger</surname><given-names>C</given-names></name><name><surname>Mathia</surname><given-names>S</given-names></name><name><surname>Venkatachalam</surname><given-names>MA</given-names></name><name><surname>Bidani</surname><given-names>AK</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Pathophysiology of unilateral ischemia-reperfusion injury: importance of renal counterbalance and implications for the AKI-CKD transition</article-title><source>American Journal of Physiology-Renal Physiology</source><volume>318</volume><fpage>F1086</fpage><lpage>F1099</lpage><pub-id pub-id-type="doi">10.1152/ajprenal.00590.2019</pub-id><pub-id pub-id-type="pmid">32174143</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ponce</surname><given-names>D</given-names></name><name><surname>Balbi</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Acute kidney injury: risk factors and management challenges in developing countries</article-title><source>International Journal of Nephrology and Renovascular Disease</source><volume>9</volume><fpage>193</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.2147/IJNRD.S104209</pub-id><pub-id pub-id-type="pmid">27578995</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prakash</surname><given-names>J</given-names></name><name><surname>de Borst</surname><given-names>MH</given-names></name><name><surname>Lacombe</surname><given-names>M</given-names></name><name><surname>Opdam</surname><given-names>F</given-names></name><name><surname>Klok</surname><given-names>PA</given-names></name><name><surname>van Goor</surname><given-names>H</given-names></name><name><surname>Meijer</surname><given-names>DKF</given-names></name><name><surname>Moolenaar</surname><given-names>F</given-names></name><name><surname>Poelstra</surname><given-names>K</given-names></name><name><surname>Kok</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Inhibition of renal rho kinase attenuates ischemia/reperfusion-induced injury</article-title><source>Journal of the American Society of Nephrology</source><volume>19</volume><fpage>2086</fpage><lpage>2097</lpage><pub-id pub-id-type="doi">10.1681/ASN.2007070794</pub-id><pub-id pub-id-type="pmid">18650485</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rabb</surname><given-names>H</given-names></name><name><surname>Mendiola</surname><given-names>CC</given-names></name><name><surname>Saba</surname><given-names>SR</given-names></name><name><surname>Dietz</surname><given-names>JR</given-names></name><name><surname>Smith</surname><given-names>CW</given-names></name><name><surname>Bonventre</surname><given-names>JV</given-names></name><name><surname>Ramirez</surname><given-names>G</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Antibodies to ICAM-1 protect kidneys in severe ischemic reperfusion injury</article-title><source>Biochemical and Biophysical Research Communications</source><volume>211</volume><fpage>67</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1006/bbrc.1995.1779</pub-id><pub-id pub-id-type="pmid">7779111</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajan</surname><given-names>V</given-names></name><name><surname>Varghese</surname><given-names>B</given-names></name><name><surname>van Leeuwen</surname><given-names>TG</given-names></name><name><surname>Steenbergen</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Review of methodological developments in laser Doppler flowmetry</article-title><source>Lasers in Medical Science</source><volume>24</volume><fpage>269</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.1007/s10103-007-0524-0</pub-id><pub-id pub-id-type="pmid">18236103</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramaswamy</surname><given-names>D</given-names></name><name><surname>Corrigan</surname><given-names>G</given-names></name><name><surname>Polhemus</surname><given-names>C</given-names></name><name><surname>Boothroyd</surname><given-names>D</given-names></name><name><surname>Scandling</surname><given-names>J</given-names></name><name><surname>Sommer</surname><given-names>FG</given-names></name><name><surname>Alfrey</surname><given-names>E</given-names></name><name><surname>Higgins</surname><given-names>J</given-names></name><name><surname>Deen</surname><given-names>WM</given-names></name><name><surname>Olshen</surname><given-names>R</given-names></name><name><surname>Myers</surname><given-names>BD</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Maintenance and recovery stages of postischemic acute renal failure in humans</article-title><source>American Journal of Physiology-Renal Physiology</source><volume>282</volume><fpage>F271</fpage><lpage>F280</lpage><pub-id pub-id-type="doi">10.1152/ajprenal.0068.2001</pub-id><pub-id pub-id-type="pmid">11788441</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Regner</surname><given-names>KR</given-names></name><name><surname>Zuk</surname><given-names>A</given-names></name><name><surname>Van Why</surname><given-names>SK</given-names></name><name><surname>Shames</surname><given-names>BD</given-names></name><name><surname>Ryan</surname><given-names>RP</given-names></name><name><surname>Falck</surname><given-names>JR</given-names></name><name><surname>Manthati</surname><given-names>VL</given-names></name><name><surname>McMullen</surname><given-names>ME</given-names></name><name><surname>Ledbetter</surname><given-names>SR</given-names></name><name><surname>Roman</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Protective effect of 20-HETE analogues in experimental renal ischemia reperfusion injury</article-title><source>Kidney International</source><volume>75</volume><fpage>511</fpage><lpage>517</lpage><pub-id pub-id-type="doi">10.1038/ki.2008.600</pub-id><pub-id pub-id-type="pmid">19052533</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rhinehart</surname><given-names>K</given-names></name><name><surname>Handelsman</surname><given-names>CA</given-names></name><name><surname>Silldorff</surname><given-names>EP</given-names></name><name><surname>Pallone</surname><given-names>TL</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>ANG II AT2 receptor modulates AT1 receptor-mediated descending vasa recta endothelial Ca2+ signaling</article-title><source>American Journal of Physiology. Heart and Circulatory Physiology</source><volume>284</volume><fpage>H779</fpage><lpage>H789</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.00317.2002</pub-id><pub-id pub-id-type="pmid">12424093</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riddick</surname><given-names>N</given-names></name><name><surname>Ohtani</surname><given-names>K</given-names></name><name><surname>Surks</surname><given-names>HK</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Targeting by myosin phosphatase-RhoA interacting protein mediates RhoA/ROCK regulation of myosin phosphatase</article-title><source>Journal of Cellular Biochemistry</source><volume>103</volume><fpage>1158</fpage><lpage>1170</lpage><pub-id pub-id-type="doi">10.1002/jcb.21488</pub-id><pub-id pub-id-type="pmid">17661354</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ronco</surname><given-names>C</given-names></name><name><surname>Reis</surname><given-names>T</given-names></name><name><surname>Husain-Syed</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Management of acute kidney injury in patients with COVID-19</article-title><source>The Lancet Respiratory Medicine</source><volume>8</volume><fpage>738</fpage><lpage>742</lpage><pub-id pub-id-type="doi">10.1016/S2213-2600(20)30229-0</pub-id><pub-id pub-id-type="pmid">32416769</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rupérez</surname><given-names>M</given-names></name><name><surname>Sánchez-López</surname><given-names>E</given-names></name><name><surname>Blanco-Colio</surname><given-names>LM</given-names></name><name><surname>Esteban</surname><given-names>V</given-names></name><name><surname>Rodríguez-Vita</surname><given-names>J</given-names></name><name><surname>Plaza</surname><given-names>JJ</given-names></name><name><surname>Egido</surname><given-names>J</given-names></name><name><surname>Ruiz-Ortega</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>The Rho-kinase pathway regulates angiotensin II-induced renal damage</article-title><source>Kidney International</source><volume>68</volume><fpage>S39</fpage><lpage>S45</lpage><pub-id pub-id-type="doi">10.1111/j.1523-1755.2005.09908.x</pub-id><pub-id pub-id-type="pmid">16336575</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanchez-Pozos</surname><given-names>K</given-names></name><name><surname>Barrera-Chimal</surname><given-names>J</given-names></name><name><surname>Garzon-Muvdi</surname><given-names>J</given-names></name><name><surname>Perez-Villalva</surname><given-names>R</given-names></name><name><surname>Rodriguez-Romo</surname><given-names>R</given-names></name><name><surname>Cruz</surname><given-names>C</given-names></name><name><surname>Gamba</surname><given-names>G</given-names></name><name><surname>Bobadilla</surname><given-names>NA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Recovery from ischemic acute kidney injury by spironolactone administration</article-title><source>Nephrology Dialysis Transplantation</source><volume>27</volume><fpage>3160</fpage><lpage>3169</lpage><pub-id pub-id-type="doi">10.1093/ndt/gfs014</pub-id><pub-id pub-id-type="pmid">22516623</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandoval</surname><given-names>RM</given-names></name><name><surname>Molitoris</surname><given-names>BA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Intravital multiphoton microscopy as a tool for studying renal physiology and pathophysiology</article-title><source>Methods</source><volume>128</volume><fpage>20</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1016/j.ymeth.2017.07.014</pub-id><pub-id pub-id-type="pmid">28733090</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaw</surname><given-names>I</given-names></name><name><surname>Rider</surname><given-names>S</given-names></name><name><surname>Mullins</surname><given-names>J</given-names></name><name><surname>Hughes</surname><given-names>J</given-names></name><name><surname>Péault</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Pericytes in the renal vasculature: roles in health and disease</article-title><source>Nature Reviews Nephrology</source><volume>14</volume><fpage>521</fpage><lpage>534</lpage><pub-id pub-id-type="doi">10.1038/s41581-018-0032-4</pub-id><pub-id pub-id-type="pmid">29942044</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shibuya</surname><given-names>M</given-names></name><name><surname>Hirai</surname><given-names>S</given-names></name><name><surname>Seto</surname><given-names>M</given-names></name><name><surname>Satoh</surname><given-names>S</given-names></name><name><surname>Ohtomo</surname><given-names>E</given-names></name><collab>Fasudil Ischemic Stroke Study Group</collab></person-group><year iso-8601-date="2005">2005</year><article-title>Effects of fasudil in acute ischemic stroke: results of a prospective placebo-controlled double-blind trial</article-title><source>Journal of the Neurological Sciences</source><volume>238</volume><fpage>31</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1016/j.jns.2005.06.003</pub-id><pub-id pub-id-type="pmid">16005902</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimokawa</surname><given-names>H</given-names></name><name><surname>Rashid</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Development of Rho-kinase inhibitors for cardiovascular medicine</article-title><source>Trends in Pharmacological Sciences</source><volume>28</volume><fpage>296</fpage><lpage>302</lpage><pub-id pub-id-type="doi">10.1016/j.tips.2007.04.006</pub-id><pub-id pub-id-type="pmid">17482681</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silldorff</surname><given-names>EP</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Pallone</surname><given-names>TL</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Prostaglandin E2 abrogates endothelin-induced vasoconstriction in renal outer medullary descending vasa recta of the rat</article-title><source>The Journal of Clinical Investigation</source><volume>95</volume><fpage>2734</fpage><lpage>2740</lpage><pub-id pub-id-type="doi">10.1172/JCI117976</pub-id><pub-id pub-id-type="pmid">7769113</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Snoeijs</surname><given-names>MG</given-names></name><name><surname>Vink</surname><given-names>H</given-names></name><name><surname>Voesten</surname><given-names>N</given-names></name><name><surname>Christiaans</surname><given-names>MH</given-names></name><name><surname>Daemen</surname><given-names>JWH</given-names></name><name><surname>Peppelenbosch</surname><given-names>AG</given-names></name><name><surname>Tordoir</surname><given-names>JH</given-names></name><name><surname>Peutz-Kootstra</surname><given-names>CJ</given-names></name><name><surname>Buurman</surname><given-names>WA</given-names></name><name><surname>Schurink</surname><given-names>GWH</given-names></name><name><surname>van Heurn</surname><given-names>LWE</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Acute ischemic injury to the renal microvasculature in human kidney transplantation</article-title><source>American Journal of Physiology. Renal Physiology</source><volume>299</volume><fpage>F1134</fpage><lpage>F1140</lpage><pub-id pub-id-type="doi">10.1152/ajprenal.00158.2010</pub-id><pub-id pub-id-type="pmid">20810613</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soga</surname><given-names>J</given-names></name><name><surname>Noma</surname><given-names>K</given-names></name><name><surname>Hata</surname><given-names>T</given-names></name><name><surname>Hidaka</surname><given-names>T</given-names></name><name><surname>Fujii</surname><given-names>Y</given-names></name><name><surname>Idei</surname><given-names>N</given-names></name><name><surname>Fujimura</surname><given-names>N</given-names></name><name><surname>Mikami</surname><given-names>S</given-names></name><name><surname>Maruhashi</surname><given-names>T</given-names></name><name><surname>Kihara</surname><given-names>Y</given-names></name><name><surname>Chayama</surname><given-names>K</given-names></name><name><surname>Kato</surname><given-names>H</given-names></name><name><surname>Liao</surname><given-names>JK</given-names></name><name><surname>Higashi</surname><given-names>Y</given-names></name><collab>ROCK Study Group</collab></person-group><year iso-8601-date="2011">2011</year><article-title>Rho-associated kinase activity, endothelial function, and cardiovascular risk factors</article-title><source>Arteriosclerosis, Thrombosis, and Vascular Biology</source><volume>31</volume><fpage>2353</fpage><lpage>2359</lpage><pub-id pub-id-type="doi">10.1161/ATVBAHA.111.227892</pub-id><pub-id pub-id-type="pmid">21737782</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>JW</given-names></name><name><surname>Zullo</surname><given-names>J</given-names></name><name><surname>Lipphardt</surname><given-names>M</given-names></name><name><surname>Dragovich</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>FX</given-names></name><name><surname>Fu</surname><given-names>B</given-names></name><name><surname>Goligorsky</surname><given-names>MS</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Endothelial glycocalyx-the battleground for complications of sepsis and kidney injury</article-title><source>Nephrology Dialysis Transplantation</source><volume>33</volume><fpage>203</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1093/ndt/gfx076</pub-id><pub-id pub-id-type="pmid">28535253</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soranno</surname><given-names>DE</given-names></name><name><surname>Gil</surname><given-names>H-W</given-names></name><name><surname>Kirkbride-Romeo</surname><given-names>L</given-names></name><name><surname>Altmann</surname><given-names>C</given-names></name><name><surname>Montford</surname><given-names>JR</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Levine</surname><given-names>A</given-names></name><name><surname>Buchanan</surname><given-names>J</given-names></name><name><surname>Faubel</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Matching Human Unilateral AKI, a Reverse Translational Approach to Investigate Kidney Recovery after Ischemia</article-title><source>Journal of the American Society of Nephrology</source><volume>30</volume><fpage>990</fpage><lpage>1005</lpage><pub-id pub-id-type="doi">10.1681/ASN.2018080808</pub-id><pub-id pub-id-type="pmid">31072827</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sutton</surname><given-names>TA</given-names></name><name><surname>Fisher</surname><given-names>CJ</given-names></name><name><surname>Molitoris</surname><given-names>BA</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Microvascular endothelial injury and dysfunction during ischemic acute renal failure</article-title><source>Kidney International</source><volume>62</volume><fpage>1539</fpage><lpage>1549</lpage><pub-id pub-id-type="doi">10.1046/j.1523-1755.2002.00631.x</pub-id><pub-id pub-id-type="pmid">12371954</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terada</surname><given-names>Y</given-names></name><name><surname>Tomita</surname><given-names>K</given-names></name><name><surname>Nonoguchi</surname><given-names>H</given-names></name><name><surname>Marumo</surname><given-names>F</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>PCR localization of angiotensin II receptor and angiotensinogen mRNAs in rat kidney</article-title><source>Kidney International</source><volume>43</volume><fpage>1251</fpage><lpage>1259</lpage><pub-id pub-id-type="doi">10.1038/ki.1993.177</pub-id><pub-id pub-id-type="pmid">8315939</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teraishi</surname><given-names>K</given-names></name><name><surname>Kurata</surname><given-names>H</given-names></name><name><surname>Nakajima</surname><given-names>A</given-names></name><name><surname>Takaoka</surname><given-names>M</given-names></name><name><surname>Matsumura</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Preventive effect of Y-27632, a selective Rho-kinase inhibitor, on ischemia/reperfusion-induced acute renal failure in rats</article-title><source>European Journal of Pharmacology</source><volume>505</volume><fpage>205</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2004.10.040</pub-id><pub-id pub-id-type="pmid">15556154</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaidya</surname><given-names>VS</given-names></name><name><surname>Ozer</surname><given-names>JS</given-names></name><name><surname>Dieterle</surname><given-names>F</given-names></name><name><surname>Collings</surname><given-names>FB</given-names></name><name><surname>Ramirez</surname><given-names>V</given-names></name><name><surname>Troth</surname><given-names>S</given-names></name><name><surname>Muniappa</surname><given-names>N</given-names></name><name><surname>Thudium</surname><given-names>D</given-names></name><name><surname>Gerhold</surname><given-names>D</given-names></name><name><surname>Holder</surname><given-names>DJ</given-names></name><name><surname>Bobadilla</surname><given-names>NA</given-names></name><name><surname>Marrer</surname><given-names>E</given-names></name><name><surname>Perentes</surname><given-names>E</given-names></name><name><surname>Cordier</surname><given-names>A</given-names></name><name><surname>Vonderscher</surname><given-names>J</given-names></name><name><surname>Maurer</surname><given-names>G</given-names></name><name><surname>Goering</surname><given-names>PL</given-names></name><name><surname>Sistare</surname><given-names>FD</given-names></name><name><surname>Bonventre</surname><given-names>JV</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies</article-title><source>Nature Biotechnology</source><volume>28</volume><fpage>478</fpage><lpage>485</lpage><pub-id pub-id-type="doi">10.1038/nbt.1623</pub-id><pub-id pub-id-type="pmid">20458318</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vassileva</surname><given-names>I</given-names></name><name><surname>Mountain</surname><given-names>C</given-names></name><name><surname>Pollock</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Functional role of ETB receptors in the renal medulla</article-title><source>Hypertension (Dallas, Tex</source><volume>41</volume><fpage>1359</fpage><lpage>1363</lpage><pub-id pub-id-type="doi">10.1161/01.HYP.0000070958.39174.7E</pub-id><pub-id pub-id-type="pmid">12719443</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Versteilen</surname><given-names>AMG</given-names></name><name><surname>Korstjens</surname><given-names>IJM</given-names></name><name><surname>Musters</surname><given-names>RJP</given-names></name><name><surname>Groeneveld</surname><given-names>ABJ</given-names></name><name><surname>Sipkema</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Rho kinase regulates renal blood flow by modulating eNOS activity in ischemia-reperfusion of the rat kidney</article-title><source>American Journal of Physiology. Renal Physiology</source><volume>291</volume><fpage>F606</fpage><lpage>F611</lpage><pub-id pub-id-type="doi">10.1152/ajprenal.00434.2005</pub-id><pub-id pub-id-type="pmid">16525157</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Versteilen</surname><given-names>AMG</given-names></name><name><surname>Blaauw</surname><given-names>N</given-names></name><name><surname>Di Maggio</surname><given-names>F</given-names></name><name><surname>Groeneveld</surname><given-names>ABJ</given-names></name><name><surname>Sipkema</surname><given-names>P</given-names></name><name><surname>Musters</surname><given-names>RJP</given-names></name><name><surname>Tangelder</surname><given-names>GJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Rho-Kinase inhibition reduces early microvascular leukocyte accumulation in the rat kidney following ischaemia-reperfusion injury: roles of nitric oxide and blood flow</article-title><source>Nephron. Experimental Nephrology</source><volume>118</volume><fpage>e79</fpage><lpage>e86</lpage><pub-id pub-id-type="doi">10.1159/000322605</pub-id><pub-id pub-id-type="pmid">21311198</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vesterinen</surname><given-names>HM</given-names></name><name><surname>Currie</surname><given-names>GL</given-names></name><name><surname>Carter</surname><given-names>S</given-names></name><name><surname>Mee</surname><given-names>S</given-names></name><name><surname>Watzlawick</surname><given-names>R</given-names></name><name><surname>Egan</surname><given-names>KJ</given-names></name><name><surname>Macleod</surname><given-names>MR</given-names></name><name><surname>Sena</surname><given-names>ES</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Systematic review and stratified meta-analysis of the efficacy of RhoA and Rho kinase inhibitors in animal models of ischaemic stroke</article-title><source>Systematic Reviews</source><volume>2</volume><elocation-id>33</elocation-id><pub-id pub-id-type="doi">10.1186/2046-4053-2-33</pub-id><pub-id pub-id-type="pmid">23687965</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Zheng</surname><given-names>XR</given-names></name><name><surname>Riddick</surname><given-names>N</given-names></name><name><surname>Bryden</surname><given-names>M</given-names></name><name><surname>Baur</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Surks</surname><given-names>HK</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>ROCK isoform regulation of myosin phosphatase and contractility in vascular smooth muscle cells</article-title><source>Circulation Research</source><volume>104</volume><fpage>531</fpage><lpage>540</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.108.188524</pub-id><pub-id pub-id-type="pmid">19131646</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>J</given-names></name><name><surname>Song</surname><given-names>J</given-names></name><name><surname>Jiang</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>G</given-names></name><name><surname>Wheeler</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Lai</surname><given-names>EY</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Buggs</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Role of intratubular pressure during the ischemic phase in acute kidney injury</article-title><source>American Journal of Physiology-Renal Physiology</source><volume>312</volume><fpage>F1158</fpage><lpage>F1165</lpage><pub-id pub-id-type="doi">10.1152/ajprenal.00527.2016</pub-id><pub-id pub-id-type="pmid">28579560</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wendel</surname><given-names>M</given-names></name><name><surname>Knels</surname><given-names>L</given-names></name><name><surname>Kummer</surname><given-names>W</given-names></name><name><surname>Koch</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Distribution of endothelin receptor subtypes ETA and ETB in the rat kidney</article-title><source>The Journal of Histochemistry and Cytochemistry</source><volume>54</volume><fpage>1193</fpage><lpage>1203</lpage><pub-id pub-id-type="doi">10.1369/jhc.5A6888.2006</pub-id><pub-id pub-id-type="pmid">16835394</pub-id></element-citation></ref><ref id="bib109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilhelm</surname><given-names>SM</given-names></name><name><surname>Simonson</surname><given-names>MS</given-names></name><name><surname>Robinson</surname><given-names>ANNV</given-names></name><name><surname>Stowe</surname><given-names>NT</given-names></name><name><surname>Schulak</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Endothelin up-regulation and localization following renal ischemia and reperfusion</article-title><source>Kidney International</source><volume>55</volume><fpage>1011</fpage><lpage>1018</lpage><pub-id pub-id-type="doi">10.1046/j.1523-1755.1999.0550031011.x</pub-id><pub-id pub-id-type="pmid">10027938</pub-id></element-citation></ref><ref id="bib110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>Y</given-names></name><name><surname>Ikegaki</surname><given-names>I</given-names></name><name><surname>Sasaki</surname><given-names>Y</given-names></name><name><surname>Uchida</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>The protein kinase inhibitor fasudil protects against ischemic myocardial injury induced by endothelin-1 in the rabbit</article-title><source>Journal of Cardiovascular Pharmacology</source><volume>35</volume><fpage>203</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1097/00005344-200002000-00005</pub-id><pub-id pub-id-type="pmid">10672851</pub-id></element-citation></ref><ref id="bib111"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>T</given-names></name><name><surname>Tada</surname><given-names>T</given-names></name><name><surname>Brodsky</surname><given-names>SV</given-names></name><name><surname>Tanaka</surname><given-names>H</given-names></name><name><surname>Noiri</surname><given-names>E</given-names></name><name><surname>Kajiya</surname><given-names>F</given-names></name><name><surname>Goligorsky</surname><given-names>MS</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Intravital videomicroscopy of peritubular capillaries in renal ischemia</article-title><source>American Journal of Physiology-Renal Physiology</source><volume>282</volume><fpage>F1150</fpage><lpage>F1155</lpage><pub-id pub-id-type="doi">10.1152/ajprenal.00310.2001</pub-id><pub-id pub-id-type="pmid">11997332</pub-id></element-citation></ref><ref id="bib112"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamasowa</surname><given-names>H</given-names></name><name><surname>Shimizu</surname><given-names>S</given-names></name><name><surname>Inoue</surname><given-names>T</given-names></name><name><surname>Takaoka</surname><given-names>M</given-names></name><name><surname>Matsumura</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Endothelial nitric oxide contributes to the renal protective effects of ischemic preconditioning</article-title><source>The Journal of Pharmacology and Experimental Therapeutics</source><volume>312</volume><fpage>153</fpage><lpage>159</lpage><pub-id pub-id-type="doi">10.1124/jpet.104.074427</pub-id><pub-id pub-id-type="pmid">15308652</pub-id></element-citation></ref><ref id="bib113"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yemisci</surname><given-names>M</given-names></name><name><surname>Gursoy-Ozdemir</surname><given-names>Y</given-names></name><name><surname>Vural</surname><given-names>A</given-names></name><name><surname>Can</surname><given-names>A</given-names></name><name><surname>Topalkara</surname><given-names>K</given-names></name><name><surname>Dalkara</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery</article-title><source>Nature Medicine</source><volume>15</volume><fpage>1031</fpage><lpage>1037</lpage><pub-id pub-id-type="doi">10.1038/nm.2022</pub-id><pub-id pub-id-type="pmid">19718040</pub-id></element-citation></ref><ref id="bib114"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ysebaert</surname><given-names>DK</given-names></name><name><surname>De Greef</surname><given-names>KE</given-names></name><name><surname>Vercauteren</surname><given-names>SR</given-names></name><name><surname>Ghielli</surname><given-names>M</given-names></name><name><surname>Verpooten</surname><given-names>GA</given-names></name><name><surname>Eyskens</surname><given-names>EJ</given-names></name><name><surname>De Broe</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Identification and kinetics of leukocytes after severe ischaemia/reperfusion renal injury</article-title><source>Nephrology, Dialysis, Transplantation</source><volume>15</volume><fpage>1562</fpage><lpage>1574</lpage><pub-id pub-id-type="doi">10.1093/ndt/15.10.1562</pub-id><pub-id pub-id-type="pmid">11007823</pub-id></element-citation></ref><ref id="bib115"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Rhinehart</surname><given-names>K</given-names></name><name><surname>Kwon</surname><given-names>W</given-names></name><name><surname>Weinman</surname><given-names>E</given-names></name><name><surname>Pallone</surname><given-names>TL</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>ANG II signaling in vasa recta pericytes by PKC and reactive oxygen species</article-title><source>American Journal of Physiology. Heart and Circulatory Physiology</source><volume>287</volume><fpage>H773</fpage><lpage>H781</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.01135.2003</pub-id><pub-id pub-id-type="pmid">15072960</pub-id></element-citation></ref><ref id="bib116"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Bhetwal</surname><given-names>BP</given-names></name><name><surname>Gunst</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2018">2018a</year><article-title>Rho kinase collaborates with p21-activated kinase to regulate actin polymerization and contraction in airway smooth muscle</article-title><source>The Journal of Physiology</source><volume>596</volume><fpage>3617</fpage><lpage>3635</lpage><pub-id pub-id-type="doi">10.1113/JP275751</pub-id><pub-id pub-id-type="pmid">29746010</pub-id></element-citation></ref><ref id="bib117"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Payne</surname><given-names>K</given-names></name><name><surname>Pallone</surname><given-names>TL</given-names></name></person-group><year iso-8601-date="2018">2018b</year><article-title>Adaptive responses of rat descending vasa recta to ischemia</article-title><source>American Journal of Physiology. Renal Physiology</source><volume>314</volume><fpage>F373</fpage><lpage>F380</lpage><pub-id pub-id-type="doi">10.1152/ajprenal.00062.2017</pub-id><pub-id pub-id-type="pmid">28814437</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.74211.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Nelson</surname><given-names>Mark T</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0155zta11</institution-id><institution>University of Vermont</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><related-object id="sa0ro1" link-type="continued-by" object-id="10.1101/2021.09.24.461675" object-id-type="id" xlink:href="https://sciety.org/articles/activity/10.1101/2021.09.24.461675"/></front-stub><body><p>This paper identifies constriction of capillary pericytes as the underlying cause of post-ischemia renal no-reflow conditions, which contribute to kidney injury in a variety of settings, including cardiac surgery, renal transplantation and severe haemorrhage. As such, it should be of considerable interest to clinicians, but also to basic researchers in vascular biology, physiology and related fields. Data obtained strongly support a role for RhoA/Rho kinase in regulating the contractility of capillary pericytes.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.74211.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Nelson</surname><given-names>Mark T</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0155zta11</institution-id><institution>University of Vermont</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Nelson</surname><given-names>Mark T</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0155zta11</institution-id><institution>University of Vermont</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="reviewer"><name><surname>Dalkara</surname><given-names>Turgay</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04kwvgz42</institution-id><institution>Hacettepe University</institution></institution-wrap><country>Turkey</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="box1"><p>Our editorial process produces two outputs: i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2021.09.24.461675">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2021.09.24.461675v1">the preprint</ext-link> for the benefit of readers; ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Pericyte-mediated constriction of renal capillaries evokes no-reflow and kidney injury following ischemia&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, including Mark T Nelson as Reviewing Editor and Reviewer #1, and the evaluation has been overseen by Martin Pollak as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Turgay Dalkara (Reviewer #3).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>1. Provide background information on pericyte contractile mechanisms in the Introduction. This should include consideration of the role of ROCK (both MLC- and endothelial cell eNOS/NO-based mechanisms) and α-SMA.</p><p>2. Elevate the impact of the paper and suitability for <italic>eLife</italic> by performing additional mechanistic studies:</p><p>a. Test whether the retinal α-SMA-dependent pericyte contraction mechanism reported by Arcon-Martinez et al., operates in the kidney.</p><p>b. Determine whether HF acts by inhibiting MLC dephosphorylation in pericytes, eNOS expression/NO activity in endothelial cells, or both, and whether the relative contribution of these mechanisms differs between the cortex and medulla.</p><p>3. Consider including a schematic depiction of the proposed model.</p><p>4. It is suggested to perform a long term experiment with assessment at 7 days from ischemia re perfusion and treatment with hydroxyfasudil.</p><p>5. It would be interesting to know the distribution of contracted pericyte profile in renal microcirculation; i.e. ensheathing type, junctional or strand-like and whether all exhibit p-MLC immunoreactivity, suggesting actomyosin contraction and, fasudil treatment differentially affects their contraction.</p><p>6. Another translationally important point could be to determine the therapeutic window of hydroxyfasudil, that is; if its beneficial effect is sustained after longer ischemia, which likely further increases pericyte contractions (Lee et al., Applied Optics, 55:9526-31, 2016). At least, this issue should be discussed. Moreover, comparison with the brain, heart and retina ischemia/no-reflow could provide some insight to assess if renal pericytes are particularly vulnerable to ischemia. Similarly, a brief comparative introduction to the renal microcirculation and capillary pericytes would be helpful for the reader.</p><p>7. Authors note that the vasculature was perfused with PBS to remove loose RBCs before perfusing PFA and FITC- albumin, so the only RBCs remaining should be those bound to the vessel walls. One would expect RBCs should be entrapped at the capillary segments where lumen was significantly narrowed by pericytes as shown in the brain (Yemisci et al., 2009; Gaudin et al., 2014). Lowering the transcardial perfusion pressure may disclose the RBC rouleaus trapped in microcirculation. This point should be taken into consideration in discussing the relevant findings.</p><p>8. Please give the rationale/reasons of having low number of rats in the medullary flow and ISCH<sup>+</sup>HF groups (n=4). Also, the stack numbers are smaller in ISCH-HF group compared to the other groups even after normalization for lower number of rats. Were these N values chosen based on power calculations?</p><p>9. Figure 1 c and d, ischemia label should read isch/rep (or I/R) in this and following figures because they were taken 30 minutes after reperfusion to indicate that the kidneys were already reperfused.</p><p>Please explain how the border of cortex and medulla are defined in non-ischemic kidney (C).</p><p>10. It looks like the shapes of the kidney sections illustrated are not from the same level so, the large vessels penetrating into the kidney cannot be seen in d and e, giving the impression that large vessels were not reperfused. Also, in E, only a few large vessels seem to be reperfused. The possibility that slow flow could also enhance fluorescence captured from large vessels should be considered.</p><p>11. Legend the last sentence could be read easier as &quot;Statistical COMPARISONS used the number of animals as the N value NOT THE STACK NUMBERS&quot;.</p><p>12. Figure 2. Only after seeing Figure 5a, I could understand how renal microcirculation looks like. In a, the merged image is not helpful, instead a graphic illustration may provide better insight to renal circulation. In b-d, please explain how the skeleton was obtained and annotate them to indicate the arterioles and capillaries.</p><p>13. Figure 3. NG2 labeling seems to be visible only on large vessels at this low power magnification. Therefore, it may be better to use symbols differentiating arterioles and pericytes.</p><p>14. Figure 5. Was Hoechst applied epidurally? If so, please give reference showing that it does not affect cellular functions. In d, control capillary diameter is around 11 µm unlike in Figure 4g. Please explain. If pre-capillary arterioles were considered as capillaries, please indicate so for comparison with the data from other labs excluding the pre-capillary arterioles.</p><p>15. Figure 6d, is very convincing so, it might be a good idea to add a label on it, indicating that pericytes made visible with p-MLC although already given above on the right.</p><p>16. Suppl. Figure c, d. Please indicate the number of animals in each treatment group.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.74211.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1. Provide background information on pericyte contractile mechanisms in the Introduction. This should include consideration of the role of ROCK (both MLC- and endothelial cell eNOS/NO-based mechanisms) and α-SMA.</p></disp-quote><p>As requested we have now discussed the molecular basis of pericyte contractility and capillary constriction.</p><p>On page 3 we highlight the previously controversial role of α-SMA-based actomyosin-mediated contraction of pericytes which has been shown to mediate capillary constriction in the ischaemic retina. We now state (on page 3, last para – page 4, para 1):</p><p>“In the retina it has been shown that … capillary constriction is mediated by α-smooth muscle actin (α-SMA) based actomyosin-mediated contraction of capillary pericytes (Alarcon-Martinez et al., 2019). In the kidney, pericytes are associated with the cortical and medullary peritubular capillaries and the descending vasa recta. As in the retina, pericyte populations in the kidney, particularly those in the descending vasa recta, are associated with α-SMA expression and contractility (Park et al., 1997; Shaw et al., 2018).</p><p>On page 4 we have added a substantial section on the Rho kinase pathway and eNOS. This states:</p><p>“An important regulator of pericyte contractility is the Rho kinase pathway (Durham et al., 2014; Kutcher et al., 2007), which inhibits myosin phosphatase, thus increasing phosphorylation of MLC and increasing contraction (Kimura et al., 1996; Maeda et al., 2003). Overactivity of Rho kinase may play a key role in hypertension and diabetes, as well as in kidney ischemia (Jahani et al., 2018; Kushiyama et al., 2013; Peng et al., 2008; Soga et al., 2011; Versteilen et al., 2006). Rho kinase may also regulate pericyte contractility by modulating actin polymerization (Kureli et al., 2020; Kutcher and Herman, 2009; Maekawa et al., 1999; Zhang et al., 2018a). In ischaemia, an important pathway by which Rho kinase inhibits myosin phosphatase is via inactivation of endothelial nitric oxide synthase (eNOS) (Versteilen et al., 2006), thus reducing production of nitric oxide (NO). NO acts on guanylate cyclase to raise the concentration of cyclic GMP, which increases MLC phosphatase activity and thus decreases contraction, so inhibiting eNOS will increase MLC phosphorylation and contraction. Thus, both the direct effect of Rho kinase (Kimura et al., 1996) and its actions on eNOS (Versteilen et al., 2006) converge to promote MLC phosphorylation and contraction. Rho kinase is an important effector of vasoconstrictors such as endothelin-1 (Prakash et al., 2008; Wilhelm et al., 1999; Yamamoto et al., 2000) and angiotensin II (Rupérez et al., 2005), but its effects on pericytes are under-studied, although it may control their contractility (Durham et al., 2014; Hartmann et al., 2021; Homma et al., 2014; Kutcher et al., 2007; Pearson et al., 2013).”</p><disp-quote content-type="editor-comment"><p>2. Elevate the impact of the paper and suitability for eLife by performing additional mechanistic studies:</p><p>a. Test whether the retinal α-SMA-dependent pericyte contraction mechanism reported by Arcon-Martinez et al., operates in the kidney.</p></disp-quote><p>We believe that the data already present in the paper demonstrate the involvement of α-SMA and actomyosin mediated contraction to a similar level of validation as the Alarcon-Martinez-papers, for the following reasons.</p><p>For the retinal pericytes, Alarcon-Martinez et al., (2018, 2019) indicated a role for α-SMA in mediating pericyte constriction in several ways. First, importantly, in their 2018 paper they demonstrated unequivocally that α-SMA is present in CNS pericytes (which had previously been controversial). Secondly, in 2019 they showed that inhibiting actin function using phalloidin, or by siRNA of α-SMA, inhibited ischaemia-evoked constriction. These data are certainly strongly suggestive of a crucial role for α-SMA, but a sceptic could point out that:</p><p>(i) phalloidin binds to all actin variants (not just α-SMA), so theoretically a different actin isoform could be involved, and</p><p>(ii) the knockdown of α-SMA in all cell types could have affected the morphology and spatial organisation of astrocytes and endothelial cells and thereby affected pericyte function.</p><p>For the kidney pericytes, we show that α-SMA protein was strongly labelled within the pericytes both surrounding the descending vasa recta and in the renal cortex (Figure 6d, i; see also Park et al., 1997), and that ischaemia greatly increased myosin light chain phosphorylation (a change known to induce smooth muscle contraction) in pericytes in both the medulla and the cortex, and that this was blocked by inhibiting the Rho kinase pathway (Figure 6e, j). Thus, our data confirm previous reports that pericytes in the kidney are associated with α-smooth muscle actin (α-SMA) expression and contractility (Shaw et al., 2018, Nat Rev Nephrol 14, 521; Park et al., 1997, Am J Physiol, 273, R1742) – indeed α-SMA is widely used as a marker for renal pericytes (Shaw et al., 2018, Nat Rev Nephrol 14, 521; Park et al., 1997, Am J Physiol, 273, R1742). Importantly, our documentation of changes in myosin light chain phosphorylation very strongly suggests that the pericyte contractility is mediated by actomyosin (rather than by a non-specific mechanism such as cell swelling).</p><p>We have now discussed the evidence supporting the idea that α-SMA-based actomyosin mediates contractility in pericytes on page 12 (para 3) to page 13 (para 1). We also explicitly state that pericyte-specific deletion of α-SMA might allow assessment of whether this is the actin isoform that confers contractility on pericytes on page 13, para 1.</p><disp-quote content-type="editor-comment"><p>b. Determine whether HF acts by inhibiting MLC dephosphorylation in pericytes, eNOS expression/NO activity in endothelial cells, or both, and whether the relative contribution of these mechanisms differs between the cortex and medulla.</p></disp-quote><p>There appears to be some misunderstanding in the referee’s question, as follows.</p><p>(1) First, hydroxyfasudil relaxes the pericytes (Figure 4g) and increases blood flow (Figure 1), which would imply that it promotes MLC dephosphorylation rather than inhibiting it.</p><p>(2) Second, in fact, we have already demonstrated in the paper that inhibition of Rho kinase with hydroxyfasudil (HF) increased MLC dephosphorylation in pericytes after ischaemia and reperfusion, as we show in Figure 6a-j.</p><p>(3) As detailed in the section described above (last para for point 1), which we have added to page 4:</p><p>“both the direct effect of Rho kinase (Kimura et al., 1996; Maeda et al., 2003) and its actions on eNOS (Versteilen et al., 2006) converge to promote MLC phosphorylation and contraction” so it is not meaningful to ask whether blocking Rho kinase acts by altering MLC phosphorylation or by altering eNOS activity, because the eNOS also ultimately acts by altering MLC phosphorylation.”</p><p>(4) It has already been shown by Versteilen et al., (2006, their Figure 2) that hydroxyfasudil’s protective effect on renal blood flow in ischaemia is very largely due to it decreasing eNOS activity. Since we have shown that the ischaemia/reperfusion-evoked reduction of renal blood flow is generated by pericytes (and not by arteriolar constriction) it is therefore expected that the effect of hydroxyfasudil on pericyte constriction will also be very largely as a result of an effect on eNOS activity.</p><p>To address the referee’s first question about eNOS, we have now:</p><p>(i) cited the Versteilen et al., (2006) paper on page 4 in the Introduction, where we also explain that the direct effect of Rho kinase and its effects via eNOS both converge on changes of MLC phosphorylation;</p><p>(ii) explained how the importance of eNOS could be confirmed by stating on page 11 (para 1) in the Results that:</p><p>“if pericyte contraction is via conventional smooth muscle actomyosin, the reduced MLC phosphorylation [in Figure 6] could explain the pericyte relaxation and increased blood flow evoked by Rho kinase inhibition. The data of Versteilen et al., (2006) suggest this is very largely mediated by inhibition of eNOS, which could be tested by quantifying the effect of eNOS block on the changes of MLC phosphorylation shown in Figure 6.”</p><p>To address the referee’s second question about pericytes in the medulla versus the cortex, we have now added extra data in response to the referee’s point 5 below. We show in the new Figure 4—figure supplement 2 that medullary and cortical pericytes tend to have a different morphology (with pericytes in the medulla having many more circumferential processes than those in the cortex). Furthermore, cortical pericytes are roughly twice as far apart as medullary pericytes. This implies that the same amount of contractile tone in medullary pericyte processes will produce more reduction of capillary diameter than it will in cortical pericytes. This has been explained on page 9, para 1, and on page 15, para 1.</p><disp-quote content-type="editor-comment"><p>3. Consider including a schematic depiction of the proposed model.</p></disp-quote><p>As requested, we have now added a schematic figure summarising the vasculature in the kidney and our findings on what happens to it in ischaemia, as a new Figure 8, and referred to it both at the start of the Introduction and at the start of the Discussion.</p><disp-quote content-type="editor-comment"><p>4. It is suggested to perform a long term experiment with assessment at 7 days from ischemia re perfusion and treatment with hydroxyfasudil.</p></disp-quote><p>Hydroxyfasudil evoked, not only an improvement of kidney perfusion, but also reduced kidney injury at 30 min after reperfusion following ischaemia, suggesting a critical role for Rho kinase in the development of renal reperfusion injury. Although we recognize that it would be interesting to carry out a long-term, translationally-oriented assessment of the effects of Rho kinase block on the outcome of kidney ischemia and reperfusion, we believe that these experiments are outside the scope of this study. The aim of the study was to investigate whether pericyte contraction contributes to reducing cortical and medullary blood flow early after ischaemia and reperfusion – an idea we have demonstrated is correct. While we expect therapeutic developments to result from this, carrying out such experiments would take a substantial investment of time, especially as our animal experimentation licence does not allow such “recovery” experiments (and it would take 6 months to obtain an amendment to the licence).</p><disp-quote content-type="editor-comment"><p>5. It would be interesting to know the distribution of contracted pericyte profile in renal microcirculation; i.e. ensheathing type, junctional or strand-like and whether all exhibit p-MLC immunoreactivity, suggesting actomyosin contraction and, fasudil treatment differentially affects their contraction.</p></disp-quote><p>We have now added, as Figure 4—figure supplement 2, representative images of pericytes on capillaries in the renal cortex and medulla. As noted above, and on page 9 (para 1) of the manuscript, cortical pericytes are roughly twice the distance apart that medullary pericytes are. The mean pericyte separation for medullary DVR capillaries (23 µm, see above) ensures that very few areas of the DVR are not associated with pericytes (Crawford et al., 2012, Nephron Physiol 120, p17). Furthermore cortical pericytes exhibit longitudinal processes but relatively few circumferential processes (thereby resembling strand-like pericytes on higher branch order capillaries in the brain), while medullary pericytes have a large number of circumferential processes (Figure 4—figure supplement 2b).</p><p>In the brain pericytes are associated both with straight capillary segments and with capillary branch points. In the kidney,the DVR are straight long capillaries that do not have many branching points (Figure 2b-d), so the branch point class of pericyte will be less common.</p><p>Despite these morphological differences between the cortical and medullary pericytes, previous researchers have shown that pericytes in both the cortex and medulla label for the contractile protein α-SMA, and we confirmed this for DVR pericytes near blockage sites (Figure 6k-n). In addition, both cortical and medullary pericytes displayed an increase in immunoreactivity for p-MLC after ischaemia and reperfusion (Figure 6). We also found that sites of ischaemia-evoked medullary and cortical capillary block were both associated with pericyte locations, and a reduced capillary diameter. The pericyte-mediated constriction and block of the descending vasa recta and cortical peritubular capillaries were also both reduced pharmacologically with hydroxyfasudil.</p><p>We have now stated all this on page 4 (para 1), page 9 (para 1) and page 15 (para 1).</p><disp-quote content-type="editor-comment"><p>6. Another translationally important point could be to determine the therapeutic window of hydroxyfasudil, that is; if its beneficial effect is sustained after longer ischemia, which likely further increases pericyte contractions (Lee et al., Applied Optics, 55:9526-31, 2016). At least, this issue should be discussed.</p></disp-quote><p>The Lee…Dalkara paper cited on the brain circulation shows that no-reflow is worse after a longer ischaemic period, but does not actually show any pericyte data, although this may well reflect more profound pericyte constriction – the only data we are are aware of showing the time course of pericyte-mediated capillary constriction is our own data on the brain microvasculature (Hall et al., 2014, Nature) but that employed chemical ischaemia as the insult which generates a more profound energy deprivation than real ischaemia. When tissue is made ischaemic it is a general finding that recovery is worse, the longer the ischaemia is applied for. We expect this to be the same for the kidney, but we have not carried out experiments to test it. We have now stated on page 13, para 2, that:</p><p>“It will be of interest to assess the efficacy of Rho kinase block for preventing kidney injury after longer periods of ischaemia than the one hour that we employed.”</p><disp-quote content-type="editor-comment"><p>Moreover, comparison with the brain, heart and retina ischemia/no-reflow could provide some insight to assess if renal pericytes are particularly vulnerable to ischemia.</p></disp-quote><p>In the brain, heart and retina, contractile pericytes on capillaries play a key role in reducing blood flow after ischemia (Yemisci et al., 2009; Hall et al., 2014; O'Farrell et al., 2017) because capillaries remain constricted by pericytes even when blood flow is restored to upstream arterioles. However, the sensitivity of pericytes in different organs to ischaemia, including, for example, whether they die in rigor, as found for profound (chemical) ischaemia in brain slices (Hall et al., 2014, Nature), will depend critically on the type of ischaemic model used and the possibility of a collateral circulation providing some nutrients (see e.g. Liu et al., 2019, J Am Heart Assoc, 8, e011220; Minhas et al., 2012, Front Neurol 11, 75; Farkas et al., 2007, Brain Res Rev 54, 162). In contrast, the kidney largely depends on the renal artery to provide a non-anastomotic supply to the glomeruli of each nephro-vascular unit (Pallone et al., 2012 Comp Physiol 2, 97; Evans et al., 2013 Clin Exp Pharmacol Physiol 40, 106). Medullary hypoxia under normal conditions has been documented in several mammalian species, including humans (Leonhardt et al., 1963, N Engl J Med 269,115; Epstein et al., 1982, Am J Physiol 243, F356-F363). The medullary partial pressure of oxygen is ~10-20 mm Hg, contrasting with the partial pressure of oxygen in the cortex, which is ~50 mm Hg (Brezis et al., 1991, J Clin Invest 88, 390; Brezis et al., 1994, Am J Physiol 267, F1059; Brezis et al., 1994 Am J Physiol 267, F1063). Thus, renal pericytes, especially in the medulla, are likely to be more susceptible to ischaemic injury than in other organs. As requested, we have now discussed all this on page 15 (para 2).</p><disp-quote content-type="editor-comment"><p>Similarly, a brief comparative introduction to the renal microcirculation and capillary pericytes would be helpful for the reader.</p></disp-quote><p>We have now added a diagram of the renal microcirculation as Figure 8. Page 3 (para 2) – page 4 (para 1) provides a brief introduction to the role of pericytes in kidney ischaemia from the perspective of what is known about the brain, retina and heart, and page 12 (para 3) – page 13 (para 1) gives a brief introduction to renal pericytes themselves.</p><disp-quote content-type="editor-comment"><p>7. Authors note that the vasculature was perfused with PBS to remove loose RBCs before perfusing PFA and FITC- albumin, so the only RBCs remaining should be those bound to the vessel walls. One would expect RBCs should be entrapped at the capillary segments where lumen was significantly narrowed by pericytes as shown in the brain (Yemisci et al., 2009; Gaudin et al., 2014). Lowering the transcardial perfusion pressure may disclose the RBC rouleaus trapped in microcirculation. This point should be taken into consideration in discussing the relevant findings.</p></disp-quote><p>We have now stated on page 14 (para 2) of the manuscript that:</p><p>“…we cannot rule out the possibility that we observed only a small percentage of red blood cells in the capillary lumen because they are more readily displaced during the perfusion with PBS and PFA followed by FITC-albumin in gelatin than with protocols that do not perform transcardial perfusion or perform it only once (Gaudin et al., 2014; Yemisci et al., 2009).”</p><disp-quote content-type="editor-comment"><p>8. Please give the rationale/reasons of having low number of rats in the medullary flow and ISCH<sup>+</sup>HF groups (n=4). Also, the stack numbers are smaller in ISCH-HF group compared to the other groups even after normalization for lower number of rats. Were these N values chosen based on power calculations?</p></disp-quote><p>Sample size estimates were not carried out prior to the study due to a lack of knowledge of effect sizes and response variance required for such calculations. Instead, once data were obtained with replicate numbers similar to those employed in previous studies, statistical analysis (reported in the paper) was used to assess the significance or otherwise of the results.</p><disp-quote content-type="editor-comment"><p>9. Figure 1 c and d, ischemia label should read isch/rep (or I/R) in this and following figures because they were taken 30 minutes after reperfusion to indicate that the kidneys were already reperfused.</p></disp-quote><p>As requested, we have now updated all the figure labels as suggested.</p><disp-quote content-type="editor-comment"><p>Please explain how the border of cortex and medulla are defined in non-ischemic kidney (C).</p></disp-quote><p>The cortex thickness, which ranges from 1.5 mm to 3 mm in rodents, was defined as the distance from the renal surface (capsule) to the base of the medullar pyramid (Nogueira et al., 2016, in vivo 30, 829; Missbach-Guentner et al., 2018, Scientific Reports 8, 1407; Andersen et al., 2020, Diagnostics (Basel) 10, 862). The FITC-albumin perfusion coupled with image threshold application also helped us to visualise the cortical vessels and medullary rays in order to define the corticomedullary boundary. This has now been stated on page 23, para 2.</p><disp-quote content-type="editor-comment"><p>10. It looks like the shapes of the kidney sections illustrated are not from the same level so, the large vessels penetrating into the kidney cannot be seen in d and e, giving the impression that large vessels were not reperfused. Also, in E, only a few large vessels seem to be reperfused. The possibility that slow flow could also enhance fluorescence captured from large vessels should be considered.</p></disp-quote><p>As requested, we have now updated the example images of the kidney sections in Figure 1.</p><disp-quote content-type="editor-comment"><p>11. Legend the last sentence could be read easier as &quot;Statistical COMPARISONS used the number of animals as the N value NOT THE STACK NUMBERS&quot;.</p></disp-quote><p>As requested, we have now updated the figure legends as suggested.</p><disp-quote content-type="editor-comment"><p>12. Figure 2. Only after seeing Figure 5a, I could understand how renal microcirculation looks like. In a, the merged image is not helpful, instead a graphic illustration may provide better insight to renal circulation. In b-d, please explain how the skeleton was obtained and annotate them to indicate the arterioles and capillaries.</p></disp-quote><p>As requested, we have now added a schematic figure (Figure 8) depicting the renal microcirculation.</p><p>For Figure 2b-d we used the ImageJ macro TubeAnalyst (Advanced Digital Microscopy Core Facility at IRB Barcelona). The basic analysis implemented by TubeAnalyst includes segmentation, skeletonization and analysis of the perfused vasculature. The perfused microvessels are demarcated with an outline on the displayed image which dynamically updates its shape in response to adjustments done using the controls included in the analysis tab. Once the outline overlay matches the vessels in the displayed image, the analysis can be carried out. On completion of the analysis, the resulting image shows an overlay, which indicates the area encompassing all vessels, a skeletal representation of the vascular network and the computed branching points inside this area. We have not annotated the skeleton because: (i) the large number of vessels shown makes this almost impossible; and (ii) the great majority of the vessels in this region of the kidney are capillaries.</p><disp-quote content-type="editor-comment"><p>13. Figure 3. NG2 labeling seems to be visible only on large vessels at this low power magnification. Therefore, it may be better to use symbols differentiating arterioles and pericytes.</p></disp-quote><p>We have now edited the figure to facilitate the distinction between arterioles and pericytes.</p><disp-quote content-type="editor-comment"><p>14. Figure 5. Was Hoechst applied epidurally? If so, please give reference showing that it does not affect cellular functions.</p></disp-quote><p>Hoechst 33342 (1 mg/kg, in 0.5 ml of sterile, isotonic saline) was administered intravenously, as described by Dunn et al., 2018, Curr Protoc Cytom 83, 12.9.1. This paper has been cited in Figure 5 legend. It is impossible to be sure that Hoechst 33342 dos not affect any cell function, but it has been used to image live cells dividing, e.g. by Kukley et al., (2008, FASEB J, 22, 2957).</p><disp-quote content-type="editor-comment"><p>In d, control capillary diameter is around 11 µm unlike in Figure 4g. Please explain. If pre-capillary arterioles were considered as capillaries, please indicate so for comparison with the data from other labs excluding the pre-capillary arterioles.</p></disp-quote><p>In Figure 5d, the control capillary diameter of around 11 µm was acquired using 2-photon in vivo imaging of the mouse renal cortex microcirculation after intraluminal FITC-albumin was given intravenously. In contrast, the control diameter in Figure 4g was acquired in the descending vasa recta (DVR) in slices of rat renal medulla after perfusion with PBS/PFA and then FITC-albumin gelatin. Post-mortem effects, as well as the PFA perfusion-fixation in the medullary slices could explain the difference between these control values.</p><p>We did not consider pre-capillary arterioles as capillaries. Only peritubular capillaries were considered for our analysis.</p><disp-quote content-type="editor-comment"><p>15. Figure 6d, is very convincing so, it might be a good idea to add a label on it, indicating that pericytes made visible with p-MLC although already given above on the right.</p></disp-quote><p>We have now edited the figure, to indicate the pericytes labelled with p-MLC.</p><disp-quote content-type="editor-comment"><p>16. Suppl. Figure c, d. Please indicate the number of animals in each treatment group.</p></disp-quote><p>As requested, we have now updated the figure legends with the number of animals for each experimental group.</p></body></sub-article></article>